{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:33:37Z","timestamp":1791318817817,"version":"4.3.1"},"reference-count":347,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2025J08178"],"award-info":[{"award-number":["2025J08178"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Joint Funds for the Innovation of Science and Technology of Fujian Province","award":["2024Y9310"],"award-info":[{"award-number":["2024Y9310"]}]},{"name":"Startup Fund for Scientific Research of Fujian Medical University Union Hospital","award":["2024XH043"],"award-info":[{"award-number":["2024XH043"]}]},{"name":"Young Elite Scientists Sponsorship Program by China Association of Chinese Medicine","award":["2024-QNRC2-B16"],"award-info":[{"award-number":["2024-QNRC2-B16"]}]},{"name":"Project funded by China Postdoctoral Science Foundation","award":["2023M741808"],"award-info":[{"award-number":["2023M741808"]}]},{"name":"Young Elite Scientists Sponsorship Program by Jiangsu Association for Science and Technology","award":["JSTJ-2023-WJ027"],"award-info":[{"award-number":["JSTJ-2023-WJ027"]}]},{"DOI":"10.13039\/501100007956","name":"Natural Science Foundation of Nanjing University of Chinese Medicine","doi-asserted-by":"crossref","award":["XZR2023036"],"award-info":[{"award-number":["XZR2023036"]}],"id":[{"id":"10.13039\/501100007956","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Foundation of Excellent Young Doctor of Jiangsu Province Hospital of Chinese Medicine","award":["2023QB0112"],"award-info":[{"award-number":["2023QB0112"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-04870-4","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:04:12Z","timestamp":1777539852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The neuroimmune axis in breast cancer: from mechanistic insights to clinical applications"],"prefix":"10.1186","volume":"24","author":[{"given":"Yimao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinya","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naijun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Yao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"4870_CR1","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/cncr.33587","volume":"127","author":"F Bray","year":"2021","unstructured":"Bray F, Laversanne M, Weiderpass E, et al. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127:3029\u201330.","journal-title":"Cancer"},{"key":"4870_CR2","first-page":"11","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, et al. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:11\u201345.","journal-title":"CA Cancer J Clin"},{"key":"4870_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcae046","volume":"6","author":"MJ Jim\u00e9nez-Santos","year":"2024","unstructured":"Jim\u00e9nez-Santos MJ, Garc\u00eda-Mart\u00edn S, Rubio-Fern\u00e1ndez M, et al. Spatial transcriptomics in breast cancer reveals tumour microenvironment-driven drug responses and clonal therapeutic heterogeneity. NAR Cancer. 2024;6:zcae046.","journal-title":"NAR Cancer"},{"key":"4870_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1083048","volume":"14","author":"K Andrade de Oliveira","year":"2023","unstructured":"Andrade de Oliveira K, Sengupta S, Yadav AK, et al. The complex nature of heterogeneity and its roles in breast cancer biology and therapeutic responsiveness. Front Endocrinol. 2023;14:1083048.","journal-title":"Front Endocrinol"},{"key":"4870_CR5","doi-asserted-by":"publisher","first-page":"27773","DOI":"10.18632\/oncotarget.25576","volume":"9","author":"R Mishra","year":"2018","unstructured":"Mishra R, Alanazi S, Yuan L, et al. Activating her3 mutations in breast cancer. Oncotarget. 2018;9:27773\u201388.","journal-title":"Oncotarget"},{"key":"4870_CR6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.celrep.2013.08.028","volume":"5","author":"N Zaman","year":"2013","unstructured":"Zaman N, Li L, Jaramillo ML, et al. Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets. Cell Rep. 2013;5:216\u201323.","journal-title":"Cell Rep"},{"key":"4870_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063146","volume":"8","author":"AP Pathak","year":"2013","unstructured":"Pathak AP, McNutt S, Shah T, et al. In vivo \u201cmri phenotyping\u201d reveals changes in extracellular matrix transport and vascularization that mediate vegf-driven increase in breast cancer metastasis. PLoS One. 2013;8:e63146.","journal-title":"PLoS One"},{"key":"4870_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg1840","volume":"9","author":"JRW Conway","year":"2023","unstructured":"Conway JRW, Din\u00e7 DD, Follain G, et al. IGFBP2 secretion by mammary adipocytes limits breast cancer invasion. Sci Adv. 2023;9:eadg1840.","journal-title":"Sci Adv"},{"key":"4870_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01515-x","volume":"21","author":"L Huang","year":"2022","unstructured":"Huang L, Rong Y, Tang X, et al. Engineered exosomes as an in situ dc-primed vaccine to boost antitumor immunity in breast cancer. Mol Cancer. 2022;21:45.","journal-title":"Mol Cancer"},{"key":"4870_CR10","doi-asserted-by":"publisher","first-page":"208","DOI":"10.21873\/cdp.10203","volume":"3","author":"K Hosoya","year":"2023","unstructured":"Hosoya K, Wakahara M, Ikeda K, et al. Perineural invasion predicts unfavorable prognosis in patients with invasive breast cancer. Cancer Diagn Progn. 2023;3:208\u201314.","journal-title":"Cancer Diagn Progn"},{"key":"4870_CR11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41523-022-00485-z","volume":"8","author":"TT Le","year":"2022","unstructured":"Le TT, Payne SL, Buckwald MN, et al. Sensory nerves enhance triple-negative breast cancer invasion and metastasis via the axon guidance molecule plexinb3. Npj Breast Cancer. 2022;8:116.","journal-title":"Npj Breast Cancer"},{"key":"4870_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1096\/fba.2021-00147","volume":"4","author":"D Li","year":"2022","unstructured":"Li D, Hu LN, Zheng SM, et al. High nerve density in breast cancer is associated with poor patient outcome. FASEB Bioadvances. 2022;4:391\u2013401.","journal-title":"FASEB Bioadvances"},{"key":"4870_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/science.adh5548","volume":"384","author":"AE Whiteley","year":"2024","unstructured":"Whiteley AE, Ma D, Wang L, et al. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis. Science. 2024;384:eadh5548.","journal-title":"Science"},{"key":"4870_CR14","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL, et al. A single-cell and spatially resolved atlas of human breast cancers. Nat Genet. 2021;53:1334\u201347.","journal-title":"Nat Genet"},{"key":"4870_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1483595","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Gong S, Liu X. Spatial transcriptomics: a new frontier in accurate localization of breast cancer diagnosis and treatment. Front Immunol. 2024;15:1483595.","journal-title":"Front Immunol"},{"key":"4870_CR16","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s10549-011-1348-y","volume":"130","author":"KS Madden","year":"2011","unstructured":"Madden KS, Szpunar MJ, Brown EB. \u03b2-adrenergic receptors (\u03b2-ar) regulate vegf and il-6 production by divergent pathways in high \u03b2-ar-expressing breast cancer cell lines. Breast Cancer Res Treat. 2011;130:747\u201358.","journal-title":"Breast Cancer Res Treat"},{"key":"4870_CR17","doi-asserted-by":"crossref","unstructured":"Xiong S-Y, Wen H-Z, Dai L-M, et al. A brain-tumor neural circuit controls breast cancer progression in mice. J Clin Invest. 2023;133:e167725.","DOI":"10.1172\/JCI167725"},{"issue":"1","key":"4870_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02241-8","volume":"10","author":"T Pu","year":"2025","unstructured":"Pu T, Sun J, Ren G, et al. Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications. Signal Transduct Target Ther. 2025;10(1):176.","journal-title":"Signal Transduct Target Ther"},{"key":"4870_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202200046","volume":"6","author":"S Hernandez","year":"2022","unstructured":"Hernandez S, Serrano AG, Solis Soto LM. The role of nerve fibers in the tumor immune microenvironment of solid tumors. Adv Biol. 2022;6:e2200046.","journal-title":"Adv Biol"},{"key":"4870_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41586-023-05968-y","volume":"618","author":"R Mancusi","year":"2023","unstructured":"Mancusi R, Monje M. The neuroscience of cancer. Nature. 2023;618:467\u201379.","journal-title":"Nature"},{"key":"4870_CR21","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/imcb.12496","volume":"99","author":"NN Scheff","year":"2021","unstructured":"Scheff NN, Saloman JL. Neuroimmunology of cancer and associated symptomology. Immunol Cell Biol. 2021;99:949\u201361.","journal-title":"Immunol Cell Biol"},{"key":"4870_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.151087","volume":"741","author":"H-J Park","year":"2024","unstructured":"Park H-J, Lee S-C, Park S-H. Norepinephrine stimulates m2 macrophage polarization via \u03b22-adrenergic receptor-mediated il-6 production in breast cancer cells. Biochem Biophys Res Commun. 2024;741:151087.","journal-title":"Biochem Biophys Res Commun"},{"key":"4870_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.imlet.2018.07.006","volume":"202","author":"E Reijmen","year":"2018","unstructured":"Reijmen E, Vannucci L, De Couck M, et al. Therapeutic potential of the vagus nerve in cancer. Immunol Lett. 2018;202:38\u201343.","journal-title":"Immunol Lett"},{"key":"4870_CR24","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1126\/science.aau9072","volume":"363","author":"MA Cox","year":"2019","unstructured":"Cox MA, Duncan GS, Lin GHY, et al. Choline acetyltransferase-expressing t cells are required to control chronic viral infection. Science. 2019;363:639\u201344.","journal-title":"Science"},{"key":"4870_CR25","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1182\/blood-2006-10-052787","volume":"109","author":"M Le\u00f3n-Ponte","year":"2007","unstructured":"Le\u00f3n-Ponte M, Ahern GP, O\u2019Connell PJ. Serotonin provides an accessory signal to enhance t-cell activation by signaling through the 5-ht7 receptor. Blood. 2007;109:3139\u201346.","journal-title":"Blood"},{"key":"4870_CR26","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.3390\/molecules26113171","volume":"26","author":"WD Gwynne","year":"2021","unstructured":"Gwynne WD, Shakeel MS, Girgis-Gabardo A, et al. The role of serotonin in breast cancer stem cells. Molecules. 2021;26:3171.","journal-title":"Molecules"},{"key":"4870_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030907","author":"YJ Cha","year":"2018","unstructured":"Cha YJ, Kim E-S, Koo JS. Amino acid transporters and glutamine metabolism in breast cancer. Int J Mol Sci. 2018;19:907.","journal-title":"Int J Mol Sci"},{"key":"4870_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41586-021-04082-1","volume":"599","author":"B Zhang","year":"2021","unstructured":"Zhang B, Vogelzang A, Miyajima M, et al. B cell-derived gaba elicits il-10+ macrophages to limit anti-tumour immunity. Nature. 2021;599:471\u20136.","journal-title":"Nature"},{"key":"4870_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1615\/CritRevOncog.2022043641","volume":"27","author":"N Ben-Jonathan","year":"2022","unstructured":"Ben-Jonathan N, Borcherding DC, Hugo ER. Dopamine receptors in breast cancer: prevalence, signaling, and therapeutic applications. Crit Rev Oncog. 2022;27:51\u201371.","journal-title":"Crit Rev Oncog"},{"key":"4870_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101212","volume":"79","author":"G Li","year":"2025","unstructured":"Li G, Jiang Y, Tong H, et al. Sciatic nerve stimulation enhances nk cell cytotoxicity through dopamine signaling and synergizes immunotherapy in triple-negative breast cancer. Drug Resist Updat. 2025;79:101212.","journal-title":"Drug Resist Updat"},{"key":"4870_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065860","volume":"8","author":"P Rameshwar","year":"2013","unstructured":"Rameshwar P, Zhao W, Huang Y, et al. Dopamine receptors modulate cytotoxicity of natural killer cells via camp-pka-creb signaling pathway. PLoS ONE. 2013;8:e65860.","journal-title":"PLoS ONE"},{"key":"4870_CR32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140100","volume":"131","author":"DN Edwards","year":"2021","unstructured":"Edwards DN, Ngwa VM, Raybuck AL, et al. Selective glutamine metabolism inhibition in tumor cells improves antitumor t lymphocyte activity in triple-negative breast cancer. J Clin Invest. 2021;131:140100.","journal-title":"J Clin Invest"},{"key":"4870_CR33","first-page":"254","volume":"42","author":"R Ruiu","year":"2023","unstructured":"Ruiu R, Cossu C, Iacoviello A, et al. Cystine\/glutamate antiporter xct deficiency reduces metastasis without impairing immune system function in breast cancer mouse models. J Exp Clin Cancer Res CR. 2023;42:254.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"4870_CR34","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/cge.13750","volume":"98","author":"S Ebrahimi","year":"2020","unstructured":"Ebrahimi S, Javid H, Alaei A, et al. New insight into the role of substance p\/neurokinin-1 receptor system in breast cancer progression and its crosstalk with micrornas. Clin Genet. 2020;98:322\u201330.","journal-title":"Clin Genet"},{"key":"4870_CR35","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/ijc.28433","volume":"134","author":"PL Rodriguez","year":"2014","unstructured":"Rodriguez PL, Jiang S, Fu Y, et al. The proinflammatory peptide substance p promotes blood-brain barrier breaching by breast cancer cells through changes in microvascular endothelial cell tight junctions. Int J Cancer. 2014;134:1034\u201344.","journal-title":"Int J Cancer"},{"key":"4870_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202200019","volume":"6","author":"LA McIlvried","year":"2022","unstructured":"McIlvried LA, Atherton MA, Horan NL, et al. Sensory neurotransmitter calcitonin gene-related peptide modulates tumor growth and lymphocyte infiltration in oral squamous cell carcinoma. Adv Biol. 2022;6:e2200019.","journal-title":"Adv Biol"},{"key":"4870_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1046\/j.1365-2567.2000.00082.x","volume":"101","author":"J Liu","year":"2000","unstructured":"Liu J, Chen M, Wang X. Calcitonin gene-related peptide inhibits lipopolysaccharide-induced interleukin-12 release from mouse peritoneal macrophages, mediated by the camp pathway. Immunology. 2000;101:61\u20137.","journal-title":"Immunology"},{"key":"4870_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1560393","volume":"16","author":"H Jin","year":"2025","unstructured":"Jin H, Meng X, Feng J. Mechanisms of tumor-associated macrophages in breast cancer and treatment strategy. Front Immunol. 2025;16:1560393.","journal-title":"Front Immunol"},{"key":"4870_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10993-1","volume":"23","author":"SA Pascetta","year":"2023","unstructured":"Pascetta SA, Kirsh SM, Cameron M, et al. Pharmacological inhibition of neuropeptide y receptors y1 and y5 reduces hypoxic breast cancer migration, proliferation, and signaling. BMC Cancer. 2023;23:494.","journal-title":"BMC Cancer"},{"key":"4870_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.705499","volume":"12","author":"S-T Lin","year":"2021","unstructured":"Lin S-T, Li Y-Z, Sun X-Q, et al. Update on the role of neuropeptide y and other related factors in breast cancer and osteoporosis. Front Endocrinol. 2021;12:705499.","journal-title":"Front Endocrinol"},{"key":"4870_CR41","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s00432-022-04365-8","volume":"149","author":"M Malekan","year":"2023","unstructured":"Malekan M, Nezamabadi SS, Samami E, et al. BDNF and its signaling in cancer. J Cancer Res Clin Oncol. 2023;149:2621\u201336.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4870_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13058-017-0844-3","volume":"19","author":"C Choy","year":"2017","unstructured":"Choy C, Ansari KI, Neman J, et al. Cooperation of neurotrophin receptor trkb and her2 in breast cancer cells facilitates brain metastases. Breast Cancer Res BCR. 2017;19:51.","journal-title":"Breast Cancer Res BCR"},{"key":"4870_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/GRF.0b013e318207ffe9","volume":"54","author":"S Pandya","year":"2011","unstructured":"Pandya S, Moore RG. Breast development and anatomy. Clin Obstet Gynecol. 2011;54:91.","journal-title":"Clin Obstet Gynecol"},{"key":"4870_CR44","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0007-1226(96)90218-0","volume":"49","author":"NS Sarhadi","year":"1996","unstructured":"Sarhadi NS, Dunn JS, Lee FD, et al. An anatomical study of the nerve supply of the breast, including the nipple and areola. Br J Plast Surg. 1996;49:156\u201364.","journal-title":"Br J Plast Surg"},{"key":"4870_CR45","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/(SICI)1098-2353(1997)10:4<283::AID-CA12>3.0.CO;2-G","volume":"10","author":"Ns Sarhadi","year":"1997","unstructured":"Sarhadi Ns, Shaw-Dunn J, Soutar Ds. Nerve supply of the breast with special reference to the nipple and areola: sir Astley Cooper revisited. Clin Anat. 1997;10:283\u20138.","journal-title":"Clin Anat"},{"key":"4870_CR46","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/ca.21301","volume":"25","author":"A Porzionato","year":"2012","unstructured":"Porzionato A, Macchi V, Stecco C, et al. Surgical anatomy of the pectoral nerves and the pectoral musculature. Clin Anat. 2012;25:559\u201375.","journal-title":"Clin Anat"},{"key":"4870_CR47","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3168\/jds.S0022-0302(96)76472-X","volume":"79","author":"CG Prosser","year":"1996","unstructured":"Prosser CG, Davis SR, Farr VC, et al. Regulation of blood flow in the mammary microvasculature. J Dairy Sci. 1996;79:1184\u201397.","journal-title":"J Dairy Sci"},{"key":"4870_CR48","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1158\/0008-5472.CAN-21-0684","volume":"81","author":"M Falcinelli","year":"2021","unstructured":"Falcinelli M, Thaker PH, Lutgendorf SK, et al. The role of psychologic stress in cancer initiation: clinical relevance and potential molecular mechanisms. Cancer Res. 2021;81:5131\u201340.","journal-title":"Cancer Res"},{"key":"4870_CR49","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1158\/1538-7445.AM2019-3440","volume":"79","author":"B Rousseau","year":"2019","unstructured":"Rousseau B, Tirupathur A, Murugan S, et al. Abstract 3440: beta-2 adrenergic receptors role in tumor aggressiveness of mda-mb-231 breast cancer cells. Cancer Res. 2019;79:3440\u20133440.","journal-title":"Cancer Res"},{"key":"4870_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/cso2.1051","volume":"3","author":"N Chatterjee","year":"2023","unstructured":"Chatterjee N, Pulipaka B, Subbalakshmi AR, et al. Unraveling the dangerous duet between cancer cell plasticity and drug resistance. Comput Syst Oncol. 2023;3:e1051.","journal-title":"Comput Syst Oncol"},{"key":"4870_CR51","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1158\/0008-5472.CAN-18-0270","volume":"78","author":"H Lu","year":"2018","unstructured":"Lu H, Tran L, Park Y, et al. Reciprocal regulation of dusp9 and dusp16 expression by hif1 controls erk and p38 map kinase activity and mediates chemotherapy-induced breast cancer stem cell enrichment. Cancer Res. 2018;78:4191\u2013202.","journal-title":"Cancer Res"},{"key":"4870_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-021-00137-1","volume":"9","author":"F Concei\u00e7\u00e3o","year":"2021","unstructured":"Concei\u00e7\u00e3o F, Sousa DM, Paredes J, et al. Sympathetic activity in breast cancer and metastasis: partners in crime. Bone Res. 2021;9:9.","journal-title":"Bone Res"},{"key":"4870_CR53","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1158\/1078-0432.CCR-19-2641","volume":"26","author":"JG Hiller","year":"2020","unstructured":"Hiller JG, Cole SW, Crone EM, et al. Preoperative \u03b2-blockade with propranolol reduces biomarkers of metastasis in breast cancer: a phase ii randomized trial. Clin Cancer Res. 2020;26:1803\u201311.","journal-title":"Clin Cancer Res"},{"key":"4870_CR54","doi-asserted-by":"crossref","unstructured":"Eliceiri BP, Qian J, Blair S. Abstract P4-04-10: pharmacological targeting of cholinergic receptors as a novel breast cancer immunotherapy. Cancer Res. 2022;82:P4-04-10.","DOI":"10.1158\/1538-7445.SABCS21-P4-04-10"},{"key":"4870_CR55","doi-asserted-by":"crossref","unstructured":"Fitzgerald PJ. Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint. Clin Epidemiol. 2012;4:151\u20136.","DOI":"10.2147\/CLEP.S33695"},{"key":"4870_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252616","volume":"16","author":"MS Al-Keilani","year":"2021","unstructured":"Al-Keilani MS, Elstaty RI, Alqudah MA, et al. Immunohistochemical expression of substance p in breast cancer and its association with prognostic parameters and ki-67 index. PLoS One. 2021;16:e0252616.","journal-title":"PLoS One"},{"key":"4870_CR57","doi-asserted-by":"crossref","unstructured":"Padmanaban V, Keller I, Seltzer ES, et al. Neuronal substance P drives metastasis through an extracellular RNA-TLR7 axis. Nature. 2024;633:207\u201315.","DOI":"10.1038\/s41586-024-07767-5"},{"key":"4870_CR58","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2022-6399","volume":"82","author":"MS Al-Keilani","year":"2022","unstructured":"Al-Keilani MS, Elstaty R, Alqudah MA. Abstract 6399: sp in relation to nk1r and ki67 predicts survival in hormone receptor negative breast cancer. Cancer Res. 2022;82:6399.","journal-title":"Cancer Res"},{"key":"4870_CR59","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1158\/0008-5472.CAN-07-1183","volume":"68","author":"E Adriaenssens","year":"2008","unstructured":"Adriaenssens E, Vanhecke E, Saule P, et al. Nerve growth factor is a potential therapeutic target in breast cancer. Cancer Res. 2008;68:346\u201351.","journal-title":"Cancer Res"},{"key":"4870_CR60","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3390\/cimb46020062","volume":"46","author":"G Ferraguti","year":"2024","unstructured":"Ferraguti G, Terracina S, Tarani L, et al. Nerve growth factor and the role of inflammation in tumor development. Curr Issues Mol Biol. 2024;46:965\u201389.","journal-title":"Curr Issues Mol Biol"},{"key":"4870_CR61","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2174\/1568009043332853","volume":"4","author":"L Doll\u00e9","year":"2004","unstructured":"Doll\u00e9 L, Adriaenssens E, El Yazidi-Belkoura I, et al. Nerve growth factor receptors and signaling in breast cancer. Curr Cancer Drug Targets. 2004;4:463\u201370.","journal-title":"Curr Cancer Drug Targets"},{"key":"4870_CR62","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3390\/cancers3010510","volume":"3","author":"NH Molloy","year":"2011","unstructured":"Molloy NH, Read DE, Gorman AM. Nerve growth factor in cancer cell death and survival. Cancers. 2011;3:511\u201330.","journal-title":"Cancers"},{"key":"4870_CR63","unstructured":"Tuo Y, Guo X, Zhang X, et al. [Effect of calcitonin gene-related peptide on proliferation and migration of human umbilical vein endothelial cells]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi Zhongguo Xiufu Chongjian Waike Zazhi Chin J Reparative Reconstr Surg. 2012;26:495\u2013500."},{"key":"4870_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.772305","volume":"11","author":"JA Harry","year":"2021","unstructured":"Harry JA, Ormiston ML. Novel pathways for targeting tumor angiogenesis in metastatic breast cancer. Front Oncol. 2021;11:772305.","journal-title":"Front Oncol"},{"key":"4870_CR65","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1158\/1078-0432.CCR-07-4214","volume":"14","author":"HP Dhakal","year":"2008","unstructured":"Dhakal HP, Naume B, Synnestvedt M, et al. Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination. Clin Cancer Res Off J Am Assoc Cancer Res. 2008;14:2341\u201350.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"4870_CR66","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.18632\/oncotarget.27553","volume":"11","author":"T Dao","year":"2020","unstructured":"Dao T, Gapihan G, Leboeuf C, et al. Expression of angiopoietin-like 4 fibrinogen-like domain (cangptl4) increases risk of brain metastases in women with breast cancer. Oncotarget. 2020;11:1590\u2013602.","journal-title":"Oncotarget"},{"key":"4870_CR67","doi-asserted-by":"publisher","first-page":"7042","DOI":"10.1158\/0008-5472.CAN-10-0522","volume":"70","author":"EK Sloan","year":"2010","unstructured":"Sloan EK, Priceman SJ, Cox BF, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010;70:7042\u201352.","journal-title":"Cancer Res"},{"key":"4870_CR68","doi-asserted-by":"crossref","unstructured":"Geyer R, Moussa M, Mandoiu I, et al. Sympathetic nervous system-mediated \u03b2-adrenergic signaling maintains the pool of mature natural killer cells. J Immunol. 2022;208:169.1.","DOI":"10.4049\/jimmunol.208.Supp.169.10"},{"key":"4870_CR69","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1002\/eji.201646395","volume":"46","author":"LD Estrada","year":"2016","unstructured":"Estrada LD, A\u011fa\u00e7 D, Farrar JD. Sympathetic neural signaling via the \u03b22\u2010adrenergic receptor suppresses t\u2010cell receptor\u2010mediated human and mouse cd8+ t\u2010cell effector function. Eur J Immunol. 2016;46:1948\u201358.","journal-title":"Eur J Immunol"},{"key":"4870_CR70","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1172\/JCI121685","volume":"129","author":"B Cui","year":"2019","unstructured":"Cui B, Luo Y, Tian P, et al. Stress-induced epinephrine enhances lactate dehydrogenase a and promotes breast cancer stem-like cells. J Clin Invest. 2019;129:1031\u201346.","journal-title":"J Clin Invest"},{"key":"4870_CR71","doi-asserted-by":"crossref","unstructured":"Zhou Y, Chu P, Wang Y, et al. Epinephrine promotes breast cancer metastasis through a ubiquitin-specific peptidase 22-mediated lipolysis circuit. Sci Adv. 2024;10:eado1533.","DOI":"10.1126\/sciadv.ado1533"},{"key":"4870_CR72","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41586-024-07767-5","volume":"633","author":"V Padmanaban","year":"2024","unstructured":"Padmanaban V, Keller I, Seltzer ES, et al. Neuronal substance p drives metastasis through an extracellular rna-tlr7 axis. Nature. 2024;633:207\u201315.","journal-title":"Nature"},{"key":"4870_CR73","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s10875-010-9370-0","volume":"30","author":"MP Negroni","year":"2010","unstructured":"Negroni MP, Fiszman GL, Azar ME, et al. Immunoglobulin g from breast cancer patients in stage i stimulates muscarinic acetylcholine receptors in mcf7 cells and induces proliferation. participation of nitric oxide synthase-derived nitric oxide. J Clin Immunol. 2010;30:474\u201384.","journal-title":"J Clin Immunol"},{"key":"4870_CR74","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10875-012-9804-y","volume":"33","author":"LT Pelegrina","year":"2013","unstructured":"Pelegrina LT, Lombardi MG, Fiszman GL, et al. Immunoglobulin g from breast cancer patients regulates mcf-7 cells migration and mmp-9 activity by stimulating muscarinic acetylcholine receptors. J Clin Immunol. 2013;33:427\u201335.","journal-title":"J Clin Immunol"},{"key":"4870_CR75","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1158\/1541-7786.MCR-09-0301","volume":"8","author":"S Sheriff","year":"2010","unstructured":"Sheriff S, Ali M, Yahya A, et al. Neuropeptide y y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic amp inhibition in a human breast cancer cell line. Mol Cancer Res. 2010;8:604\u201314.","journal-title":"Mol Cancer Res"},{"key":"4870_CR76","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-016-0559-6","volume":"15","author":"J Gautam","year":"2016","unstructured":"Gautam J, Banskota S, Regmi SC, et al. Tryptophan hydroxylase 1 and 5-ht(7) receptor preferentially expressed in triple-negative breast cancer promote cancer progression through autocrine serotonin signaling. Mol Cancer. 2016;15:75.","journal-title":"Mol Cancer"},{"key":"4870_CR77","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41416-019-0640-1","volume":"122","author":"M Sola-Penna","year":"2020","unstructured":"Sola-Penna M, Paix\u00e3o LP, Branco JR, et al. Serotonin activates glycolysis and mitochondria biogenesis in human breast cancer cells through activation of the jak1\/stat3\/erk1\/2 and adenylate cyclase\/pka, respectively. Br J Cancer. 2020;122:194\u2013208.","journal-title":"Br J Cancer"},{"key":"4870_CR78","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.mce.2011.08.031","volume":"348","author":"A Valdehita","year":"2012","unstructured":"Valdehita A, Carmena MJ, Bajo AM, et al. RNA interference-directed silencing of vpac1 receptor inhibits vip effects on both egfr and her2 transactivation and vegf secretion in human breast cancer cells. Mol Cell Endocrinol. 2012;348:241\u20136.","journal-title":"Mol Cell Endocrinol"},{"key":"4870_CR79","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.regpep.2007.06.006","volume":"144","author":"A Valdehita","year":"2007","unstructured":"Valdehita A, Carmena MJ, Collado B, et al. Vasoactive intestinal peptide (vip) increases vascular endothelial growth factor (vegf) expression and secretion in human breast cancer cells. Regul Pept. 2007;144:101\u20138.","journal-title":"Regul Pept"},{"key":"4870_CR80","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10286-020-00724-y","volume":"31","author":"A Kamiya","year":"2021","unstructured":"Kamiya A, Hiyama T, Fujimura A, et al. Sympathetic and parasympathetic innervation in cancer: therapeutic implications. Clin Auton Res Off J Clin Auton Res Soc. 2021;31:165\u201378.","journal-title":"Clin Auton Res Off J Clin Auton Res Soc"},{"key":"4870_CR81","doi-asserted-by":"publisher","first-page":"R81","DOI":"10.1186\/bcr2448","volume":"11","author":"VP Pai","year":"2009","unstructured":"Pai VP, Marshall AM, Hernandez LL, et al. Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival. Breast Cancer Res. 2009;11:R81.","journal-title":"Breast Cancer Res"},{"key":"4870_CR82","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10549-016-4027-1","volume":"161","author":"J Gautam","year":"2017","unstructured":"Gautam J, Bae YK, Kim J-A. Up-regulation of cathepsin s expression by hsp90 and 5-ht7 receptor-dependent serotonin signaling correlates with triple negativity of human breast cancer. Breast Cancer Res Treat. 2017;161:29\u201340.","journal-title":"Breast Cancer Res Treat"},{"key":"4870_CR83","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jad.2009.12.022","volume":"124","author":"L Grassi","year":"2010","unstructured":"Grassi L, Rossi E, Cobianchi M, et al. Depression and serotonin transporter (5-httlpr) polymorphism in breast cancer patients. J Affect Disord. 2010;124:346\u201350.","journal-title":"J Affect Disord"},{"key":"4870_CR84","doi-asserted-by":"publisher","first-page":"c693","DOI":"10.1136\/bmj.c693","volume":"340","author":"CM Kelly","year":"2010","unstructured":"Kelly CM, Juurlink DN, Gomes T, et al. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. BMJ. 2010;340:c693\u2013c693.","journal-title":"BMJ"},{"key":"4870_CR85","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1741-7015-8-90","volume":"8","author":"J Ashbury","year":"2010","unstructured":"Ashbury J, L\u00e9vesque L, Beck P, et al. A population-based case-control study of selective serotonin reuptake inhibitors (ssris) and breast cancer: the impact of duration of use, cumulative dose and latency. BMC Med. 2010;8:90.","journal-title":"BMC Med"},{"key":"4870_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-017-0928-0","volume":"20","author":"J Busby","year":"2018","unstructured":"Busby J, Mills K, Zhang S-D, et al. Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study. Breast Cancer Res. 2018;20:4.","journal-title":"Breast Cancer Res"},{"key":"4870_CR87","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4048\/jbc.2023.26.e25","volume":"26","author":"M Jin","year":"2023","unstructured":"Jin M, Wang Y, Zhou T, et al. Norepinephrine\/\u03b22-adrenergic receptor pathway promotes the cell proliferation and nerve growth factor production in triple-negative breast cancer. J Breast Cancer. 2023;26:268\u201385.","journal-title":"J Breast Cancer"},{"key":"4870_CR88","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bbi.2015.12.014","volume":"53","author":"MJ Szpunar","year":"2016","unstructured":"Szpunar MJ, Belcher EK, Dawes RP, et al. Sympathetic innervation, norepinephrine content, and norepinephrine turnover in orthotopic and spontaneous models of breast cancer. Brain Behav Immun. 2016;53:223\u201333.","journal-title":"Brain Behav Immun"},{"key":"4870_CR89","first-page":"1170","volume":"19","author":"L-P Wang","year":"2015","unstructured":"Wang L-P, Jin J, Lv F-F, et al. Norepinephrine attenuates cxcr4 expression and the corresponding invasion of mda-mb-231 breast cancer cells via \u03b22-adrenergic receptors. Eur Rev Med Pharmacol Sci. 2015;19:1170\u201381.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4870_CR90","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3892\/ijo.2015.3038","volume":"47","author":"A Barbieri","year":"2015","unstructured":"Barbieri A, Bimonte S, Palma G, et al. The stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo. Int J Oncol. 2015;47:527\u201334.","journal-title":"Int J Oncol"},{"key":"4870_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225626","volume":"20","author":"P Avril","year":"2019","unstructured":"Avril P, Vidal L, Barille-Nion S, et al. Epinephrine infiltration of adipose tissue impacts mcf7 breast cancer cells and total lipid content. Int J Mol Sci. 2019;20:5626.","journal-title":"Int J Mol Sci"},{"key":"4870_CR92","doi-asserted-by":"publisher","first-page":"9565","DOI":"10.3390\/ijms21249565","volume":"21","author":"E Tremmel","year":"2020","unstructured":"Tremmel E, Kuhn C, Kaltofen T, et al. L-dopa-decarboxylase (ddc) is a positive prognosticator for breast cancer patients and epinephrine regulates breast cancer cell (mcf7 and t47d) growth in vitro according to their different expression of gi- protein- coupled receptors. Int J Mol Sci. 2020;21:9565.","journal-title":"Int J Mol Sci"},{"key":"4870_CR93","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3390\/biology12111418","volume":"12","author":"JP Mu\u00f1oz","year":"2023","unstructured":"Mu\u00f1oz JP, Calaf GM. Acetylcholine, another factor in breast cancer. Biology. 2023;12:1418.","journal-title":"Biology"},{"key":"4870_CR94","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.semcancer.2021.03.016","volume":"76","author":"GM Calaf","year":"2021","unstructured":"Calaf GM. Role of organophosphorous pesticides and acetylcholine in breast carcinogenesis. Semin Cancer Biol. 2021;76:206\u201317.","journal-title":"Semin Cancer Biol"},{"key":"4870_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/biom15060835","author":"X Feng","year":"2025","unstructured":"Feng X, Tian Y, Guo X, et al. \u03919 nicotinic acetylcholine receptor promotes tumor proliferation and suppresses ferroptosis in triple-negative breast cancer. Biomolecules. 2025;15:835.","journal-title":"Biomolecules"},{"key":"4870_CR96","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s10456-024-09944-6","volume":"27","author":"S Ochirbat","year":"2024","unstructured":"Ochirbat S, Kan T-C, Hsu C-C, et al. The angiogenic role of the alpha 9-nicotinic acetylcholine receptor in triple-negative breast cancers. Angiogenesis. 2024;27:827\u201343.","journal-title":"Angiogenesis"},{"key":"4870_CR97","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/md18040195","volume":"18","author":"Z Sun","year":"2020","unstructured":"Sun Z, Bao J, Zhangsun M, et al. \u0391O-conotoxin gexiva inhibits the growth of breast cancer cells via interaction with \u03b19 nicotine acetylcholine receptors. Mar Drugs. 2020;18:195.","journal-title":"Mar Drugs"},{"key":"4870_CR98","unstructured":"Cox MA, Duncan GS, Lin GHY, et al. Choline acetyltransferase-expressing T cells are required to control chronic viral infection. Science. 2019;366:eaau9072."},{"key":"4870_CR99","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13046-023-02836-5","volume":"42","author":"J Pan","year":"2023","unstructured":"Pan J, Zhang L, Wang X, et al. Chronic stress induces pulmonary epithelial cells to produce acetylcholine that remodels lung pre-metastatic niche of breast cancer by enhancing netosis. J Exp Clin Cancer Res. 2023;42:255.","journal-title":"J Exp Clin Cancer Res"},{"key":"4870_CR100","doi-asserted-by":"crossref","unstructured":"Liang Y, Yang Q. The role of circular rnas in glucose metabolic reprogramming: impact on cancer progression and therapeutic implications in breast cancer. J Cancer Metastasis Treat. 2025.","DOI":"10.20517\/2394-4722.2024.93"},{"key":"4870_CR101","volume":"5","author":"A Deng","year":"2025","unstructured":"Deng A, Fan R, Gou J, et al. Innovative pdk1-degrading protacs transform cancer aerobic glycolysis and induce immunogenic cell death in breast cancer. Explor Beijing China. 2025;5:e20240031.","journal-title":"Explor Beijing China"},{"key":"4870_CR102","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/his.13334","volume":"72","author":"R El Ansari","year":"2018","unstructured":"El Ansari R, McIntyre A, Craze ML, et al. Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations. Histopathology. 2018;72:183\u201390.","journal-title":"Histopathology"},{"key":"4870_CR103","first-page":"1","volume":"34","author":"Y Wu","year":"2026","unstructured":"Wu Y, Liu Y, Sun R, et al. Circular rnas: key regulators of tumor metabolic reprogramming and clinical translation. Oncol Res. 2026;34:1.","journal-title":"Oncol Res"},{"key":"4870_CR104","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.7150\/thno.80544","volume":"13","author":"N Li","year":"2023","unstructured":"Li N, Xu X, Liu D, et al. The delta subunit of the gabaa receptor is necessary for the gpt2-promoted breast cancer metastasis. Theranostics. 2023;13:1355\u201369.","journal-title":"Theranostics"},{"key":"4870_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216653","volume":"586","author":"Z Tan","year":"2024","unstructured":"Tan Z, Boyapati K, Tressler CM, et al. Glutamine transporter slc38a3 promotes breast cancer metastasis via gsk3\u03b2\/\u03b2-catenin\/emt pathway. Cancer Lett. 2024;586:216653.","journal-title":"Cancer Lett"},{"key":"4870_CR106","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70131","volume":"14","author":"C He","year":"2024","unstructured":"He C, Peng M, Zeng X, et al. Microenvironmental g protein-coupled estrogen receptor-mediated glutamine metabolic coupling between cancer-associated fibroblasts and triple-negative breast cancer cells governs tumour progression. Clin Transl Med. 2024;14:e70131.","journal-title":"Clin Transl Med"},{"key":"4870_CR107","doi-asserted-by":"publisher","first-page":"435","DOI":"10.26444\/aaem\/75891","volume":"24","author":"A Brzozowska","year":"2017","unstructured":"Brzozowska A, Burdan F, Duma D, et al. \u03b3-amino butyric acid (gaba) level as an overall survival risk factor in breast cancer. Ann Agric Environ Med AAEM. 2017;24:435\u20139.","journal-title":"Ann Agric Environ Med AAEM"},{"key":"4870_CR108","doi-asserted-by":"publisher","first-page":"1108823","DOI":"10.3389\/fonc.2023.1108823","volume":"13","author":"L Yang","year":"2023","unstructured":"Yang L, Zhu J, Wang L, et al. A novel risk score model based on gamma-aminobutyric acid signature predicts the survival prognosis of patients with breast cancer. Front Oncol. 2023;13:1108823.","journal-title":"Front Oncol"},{"key":"4870_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115464","volume":"210","author":"S Li","year":"2023","unstructured":"Li S, Zeng H, Fan J, et al. Glutamine metabolism in breast cancer and possible therapeutic targets. Biochem Pharmacol. 2023;210:115464.","journal-title":"Biochem Pharmacol"},{"key":"4870_CR110","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1038\/onc.2015.369","volume":"35","author":"DC Borcherding","year":"2016","unstructured":"Borcherding DC, Tong W, Hugo ER, et al. Expression and therapeutic targeting of dopamine receptor-1 (d1r) in breast cancer. Oncogene. 2016;35:3103\u201313.","journal-title":"Oncogene"},{"key":"4870_CR111","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2174\/1570163815666180130101421","volume":"16","author":"H Bakhtou","year":"2019","unstructured":"Bakhtou H, Olfatbakhsh A, Deezagi A, et al. The expression of dopamine receptors gene and their potential role in targeting breast cancer cells with selective agonist and antagonist drugs. Could it be the novel insight to therapy? Curr Drug Discov Technol. 2019;16:184\u201397.","journal-title":"Curr Drug Discov Technol"},{"key":"4870_CR112","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22693","volume":"35","author":"S Bandyopadhayaya","year":"2021","unstructured":"Bandyopadhayaya S, Akimov MG, Verma R, et al. N-arachidonoyl dopamine inhibits epithelial-mesenchymal transition of breast cancer cells through erk signaling and decreasing the cellular cholesterol. J Biochem Mol Toxicol. 2021;35:e22693.","journal-title":"J Biochem Mol Toxicol"},{"key":"4870_CR113","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s40618-024-02492-2","volume":"48","author":"L Dery","year":"2024","unstructured":"Dery L, Shimon I, Rudman Y, et al. Breast cancer risk in patients with dopamine agonist-treated hyperprolactinemia. J Endocrinol Invest. 2024;48:691\u20139.","journal-title":"J Endocrinol Invest"},{"key":"4870_CR114","doi-asserted-by":"publisher","first-page":"6546","DOI":"10.3390\/ijms25126546","volume":"25","author":"T Sirek","year":"2024","unstructured":"Sirek T, Sirek A, Borawski P, et al. Expression profiles of dopamine-related genes and mirnas regulating their expression in breast cancer. Int J Mol Sci. 2024;25:6546.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4870_CR115","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1124\/jpet.123.001965","volume":"390","author":"M Steeves","year":"2024","unstructured":"Steeves M, Combita D, Whelan W, et al. Chemotherapeutics-loaded poly(dopamine) core-shell nanoparticles for breast cancer treatment. J Pharmacol Exp Ther. 2024;390(1):78\u201387.","journal-title":"J Pharmacol Exp Ther"},{"key":"4870_CR116","doi-asserted-by":"publisher","DOI":"10.1007\/s10142-023-01007-1","volume":"23","author":"Z Wang","year":"2023","unstructured":"Wang Z, Mehmood A, Yao J, et al. Combination of furosemide, gold, and dopamine as a potential therapy for breast cancer. Funct Integr Genomics. 2023;23:94.","journal-title":"Funct Integr Genomics"},{"key":"4870_CR117","first-page":"4636","volume":"61","author":"JC Reubi","year":"2001","unstructured":"Reubi JC, Gugger M, Waser B, et al. Y(1)-mediated effect of neuropeptide y in cancer: breast carcinomas as targets. Cancer Res. 2001;61:4636\u201341.","journal-title":"Cancer Res"},{"key":"4870_CR118","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ijc.26350","volume":"131","author":"PJ Medeiros","year":"2012","unstructured":"Medeiros PJ, Al-Khazraji BK, Novielli NM, et al. Neuropeptide y stimulates proliferation and migration in the 4t1 breast cancer cell line. Int J Cancer. 2012;131:276\u201386.","journal-title":"Int J Cancer"},{"key":"4870_CR119","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1158\/0008-5472.CAN-05-2744","volume":"66","author":"H Amlal","year":"2006","unstructured":"Amlal H, Faroqui S, Balasubramaniam A, et al. Estrogen up-regulates neuropeptide y y1 receptor expression in a human breast cancer cell line. Cancer Res. 2006;66:3706\u201314.","journal-title":"Cancer Res"},{"key":"4870_CR120","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1021\/acs.jmedchem.6b00043","volume":"59","author":"D B\u00f6hme","year":"2016","unstructured":"B\u00f6hme D, Krieghoff J, Beck-Sickinger AG. Double methotrexate-modified neuropeptide y analogues express increased toxicity and overcome drug resistance in breast cancer cells. J Med Chem. 2016;59:3409\u201317.","journal-title":"J Med Chem"},{"key":"4870_CR121","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1021\/acsami.5b00270","volume":"7","author":"J Li","year":"2015","unstructured":"Li J, Shen Z, Ma X, et al. Neuropeptide y y1 receptors meditate targeted delivery of anticancer drug with encapsulated nanoparticles to breast cancer cells with high selectivity and its potential for breast cancer therapy. ACS Appl Mater Interfaces. 2015;7:5574\u201382.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4870_CR122","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1021\/mp500601z","volume":"12","author":"S Hofmann","year":"2015","unstructured":"Hofmann S, Maschauer S, Kuwert T, et al. Synthesis and in vitro and in vivo evaluation of an18 f-labeled neuropeptide y analogue for imaging of breast cancer by pet. Mol Pharm. 2015;12:1121\u201330.","journal-title":"Mol Pharm"},{"key":"4870_CR123","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.biomaterials.2016.11.028","volume":"116","author":"J Li","year":"2017","unstructured":"Li J, Tian Y, Shan D, et al. Neuropeptide y y1 receptor-mediated biodegradable photoluminescent nanobubbles as ultrasound contrast agents for targeted breast cancer imaging. Biomaterials. 2017;116:106\u201317.","journal-title":"Biomaterials"},{"key":"4870_CR124","doi-asserted-by":"publisher","first-page":"11280","DOI":"10.1021\/acs.jpclett.1c03562","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Cao Y, Jiang Z, et al. The neuropeptide y1 receptor ligand-modified cell membrane promotes targeted photodynamic therapy of zeolitic imidazolate frameworks for breast cancer. J Phys Chem Lett. 2021;12:11280\u20137.","journal-title":"J Phys Chem Lett"},{"key":"4870_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118117","volume":"187","author":"K Tomi\u0107","year":"2025","unstructured":"Tomi\u0107 K, Kostev\u0161ek N, Romeo S, et al. Neuropeptide y receptors 1 and 2 as molecular targets in prostate and breast cancer therapy. Biomed Pharmacother. 2025;187:118117.","journal-title":"Biomed Pharmacother"},{"key":"4870_CR126","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00726-014-1736-9","volume":"46","author":"M Mu\u00f1oz","year":"2014","unstructured":"Mu\u00f1oz M, Cove\u00f1as R. Involvement of substance p and the nk-1 receptor in human pathology. Amino Acids. 2014;46:1727\u201350.","journal-title":"Amino Acids"},{"key":"4870_CR127","doi-asserted-by":"publisher","first-page":"6424","DOI":"10.1158\/0008-5472.CAN-12-4573","volume":"73","author":"S Garcia-Recio","year":"2013","unstructured":"Garcia-Recio S, Fuster G, Fernandez-Nogueira P, et al. Substance p autocrine signaling contributes to persistent her2 activation that drives malignant progression and drug resistance in breast cancer. Cancer Res. 2013;73:6424\u201334.","journal-title":"Cancer Res"},{"key":"4870_CR128","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.cellsig.2015.03.015","volume":"27","author":"J-G Wang","year":"2015","unstructured":"Wang J-G, Yu J, Hu J-L, et al. Neurokinin-1 activation affects egfr related signal transduction in triple negative breast cancer. Cell Signal. 2015;27:1315\u201324.","journal-title":"Cell Signal"},{"key":"4870_CR129","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/ijc.20410","volume":"112","author":"K Lang","year":"2004","unstructured":"Lang K, Drell TL, Lindecke A, et al. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer. 2004;112:231\u20138.","journal-title":"Int J Cancer"},{"key":"4870_CR130","doi-asserted-by":"publisher","first-page":"1959270","DOI":"10.1155\/2016\/1959270","volume":"2016","author":"P Robinson","year":"2016","unstructured":"Robinson P, Kasembeli M, Bharadwaj U, et al. Substance p receptor signaling mediates doxorubicin-induced cardiomyocyte apoptosis and triple-negative breast cancer chemoresistance. Biomed Res Int. 2016;2016:1959270.","journal-title":"Biomed Res Int"},{"key":"4870_CR131","doi-asserted-by":"publisher","DOI":"10.1177\/17448069211024082","volume":"17","author":"S Gutierrez","year":"2021","unstructured":"Gutierrez S, Eisenach JC, Boada MD. Seeding of breast cancer cell line (mda-mb-231LUC+ ) to the mandible induces overexpression of substance p and cgrp throughout the trigeminal ganglion and widespread peripheral sensory neuropathy throughout all three of its divisions. Mol Pain. 2021;17:17448069211024082.","journal-title":"Mol Pain"},{"key":"4870_CR132","doi-asserted-by":"publisher","first-page":"153303381987516","DOI":"10.1177\/1533033819875168","volume":"18","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Wang M, Tong Y, et al. MiR-206 promotes cancer progression by targeting full-length neurokinin-1 receptor in breast cancer. Technol Cancer Res Treat. 2019;18:1533033819875168.","journal-title":"Technol Cancer Res Treat"},{"key":"4870_CR133","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12527","volume":"52","author":"L Zhang","year":"2019","unstructured":"Zhang L, Wang L, Dong D, et al. MiR-34b\/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis. Cell Prolif. 2019;52:e12527.","journal-title":"Cell Prolif"},{"key":"4870_CR134","doi-asserted-by":"crossref","unstructured":"Wu Y, Chen Z, Lee J, et al. Circular RNAs: Epigenetic Puppeteers Pulling the Strings of Cancer Pathogenesis. Med Bull. 2026;2:124\u201336.","DOI":"10.1002\/mdb2.70022"},{"key":"4870_CR135","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/med4.70018","volume":"3","author":"J Si","year":"2025","unstructured":"Si J, Liang C, Zhang X, et al. LINC00922: a critical oncogenic long non-coding rna involved in cancer progression, chemotherapy resistance, and microrna regulation. Med Adv. 2025;3:65\u201379.","journal-title":"Med Adv"},{"key":"4870_CR136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0292452","volume":"18","author":"L Xie","year":"2023","unstructured":"Xie L, Xiao W, Fang H, et al. RAMP1 as a novel prognostic biomarker in pan-cancer and osteosarcoma. PLoS One. 2023;18:e0292452.","journal-title":"PLoS One"},{"key":"4870_CR137","doi-asserted-by":"publisher","first-page":"5740","DOI":"10.1158\/1078-0432.CCR-13-1712","volume":"19","author":"LL Nikitenko","year":"2013","unstructured":"Nikitenko LL, Leek R, Henderson S, et al. The g-protein-coupled receptor clr is upregulated in an autocrine loop with adrenomedullin in clear cell renal cell carcinoma and associated with poor prognosis. Clin Cancer Res. 2013;19:5740\u20138.","journal-title":"Clin Cancer Res"},{"key":"4870_CR138","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41586-024-07237-y","volume":"628","author":"Y-Z Lu","year":"2024","unstructured":"Lu Y-Z, Nayer B, Singh SK, et al. CGRP sensory neurons promote tissue healing via neutrophils and macrophages. Nature. 2024;628:604\u201311.","journal-title":"Nature"},{"issue":"196","key":"4870_CR139","first-page":"2181","volume":"2016","author":"W Ding","year":"1950","unstructured":"Ding W, Stohl LL, Xu L, et al. Calcitonin gene-related peptide-exposed endothelial cells bias antigen presentation to cd4+ t cells toward a th17 response. J Immunol Baltim Md. 1950;2016(196):2181\u201394.","journal-title":"J Immunol Baltim Md"},{"key":"4870_CR140","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/MED.0000000000000218","volume":"23","author":"TW Moody","year":"2016","unstructured":"Moody TW, Nuche-Berenguer B, Jensen RT. Vasoactive intestinal peptide\/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer. Curr Opin Endocrinol Diabetes Obes. 2016;23:38\u201347.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"4870_CR141","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2967\/jnumed.112.114876","volume":"54","author":"ML Thakur","year":"2013","unstructured":"Thakur ML, Zhang K, Berger A, et al. VPAC1 receptors for imaging breast cancer: a feasibility study. J Nucl Med. 2013;54:1019\u201325.","journal-title":"J Nucl Med"},{"key":"4870_CR142","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1158\/1078-0432.CCR-10-1890","volume":"17","author":"E Vanhecke","year":"2011","unstructured":"Vanhecke E, Adriaenssens E, Verbeke S, et al. Brain-derived neurotrophic factor and neurotrophin-4\/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival. Clin Cancer Res. 2011;17:1741\u201352.","journal-title":"Clin Cancer Res"},{"key":"4870_CR143","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.cytogfr.2012.06.004","volume":"23","author":"H Hondermarck","year":"2012","unstructured":"Hondermarck H. Neurotrophins and their receptors in breast cancer. Cytokine Growth Factor Rev. 2012;23:357\u201365.","journal-title":"Cytokine Growth Factor Rev"},{"key":"4870_CR144","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178173","volume":"12","author":"Y-F Tsai","year":"2017","unstructured":"Tsai Y-F, Tseng L-M, Hsu C-Y, et al. Brain-derived neurotrophic factor (bdnf) -trkb signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer. PLoS One. 2017;12:e0178173.","journal-title":"PLoS One"},{"key":"4870_CR145","first-page":"2031","volume":"17","author":"L Meng","year":"2019","unstructured":"Meng L, Liu B, Ji R, et al. Targeting the bdnf\/trkb pathway for the treatment of tumors. Oncol Lett. 2019;17:2031\u20139.","journal-title":"Oncol Lett"},{"key":"4870_CR146","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1038\/onc.2012.417","volume":"32","author":"E Louie","year":"2013","unstructured":"Louie E, Chen XF, Coomes A, et al. Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis. Oncogene. 2013;32:4064\u201377.","journal-title":"Oncogene"},{"key":"4870_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122282","volume":"336","author":"Y Wang","year":"2024","unstructured":"Wang Y, Liang J, Xu B, et al. TrkB\/bdnf signaling pathway and its small molecular agonists in cns injury. Life Sci. 2024;336:122282.","journal-title":"Life Sci"},{"key":"4870_CR148","first-page":"255","volume":"42","author":"J Pan","year":"2023","unstructured":"Pan J, Zhang L, Wang X, et al. Chronic stress induces pulmonary epithelial cells to produce acetylcholine that remodels lung pre-metastatic niche of breast cancer by enhancing netosis. J Exp Clin Cancer Res CR. 2023;42:255.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"4870_CR149","doi-asserted-by":"publisher","first-page":"34","DOI":"10.7150\/thno.29407","volume":"9","author":"X Chen","year":"2019","unstructured":"Chen X, Cao Q, Liao R, et al. Loss of abat-mediated gabaergic system promotes basal-like breast cancer progression by activating ca(2+)-nfat1 axis. Theranostics. 2019;9:34\u201347.","journal-title":"Theranostics"},{"key":"4870_CR150","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s12013-023-01171-y","volume":"81","author":"S Jafarinezhad","year":"2023","unstructured":"Jafarinezhad S, Assaran Darban R, Javid H, et al. The sp\/nk1r system promotes the proliferation of breast cancer cells through nf-\u03bab-mediated inflammatory responses. Cell Biochem Biophys. 2023;81:787\u201394.","journal-title":"Cell Biochem Biophys"},{"key":"4870_CR151","doi-asserted-by":"publisher","first-page":"1528363","DOI":"10.3389\/fimmu.2025.1528363","volume":"16","author":"J Wen","year":"2025","unstructured":"Wen J, Li Y, Deng W, et al. Central nervous system and immune cells interactions in cancer: unveiling new therapeutic avenues. Front Immunol. 2025;16:1528363.","journal-title":"Front Immunol"},{"key":"4870_CR152","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02219-0","volume":"24","author":"Q Huang","year":"2025","unstructured":"Huang Q, Hu B, Zhang P, et al. Neuroscience of cancer: unraveling the complex interplay between the nervous system, the tumor and the tumor immune microenvironment. Mol Cancer. 2025;24:24.","journal-title":"Mol Cancer"},{"key":"4870_CR153","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.ccell.2024.05.007","volume":"42","author":"N Layer","year":"2024","unstructured":"Layer N, Bunse L, Venkataramani V. Neural deception: breast cancer co-opts neuronal mechanisms to evade the immune system. Cancer Cell. 2024;42:936\u20138.","journal-title":"Cancer Cell"},{"key":"4870_CR154","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrc3978","volume":"15","author":"SW Cole","year":"2015","unstructured":"Cole SW, Nagaraja AS, Lutgendorf SK, et al. Sympathetic nervous system regulation of the tumour microenvironment. Nat Rev Cancer. 2015;15:563\u201372.","journal-title":"Nat Rev Cancer"},{"key":"4870_CR155","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/13651501.2020.1782433","volume":"24","author":"M Ghaffari Darab","year":"2020","unstructured":"Ghaffari Darab M, Hedayati A, Khorasani E, et al. Selective serotonin reuptake inhibitors in major depression disorder treatment: an umbrella review on systematic reviews. Int J Psychiatry Clin Pract. 2020;24:357\u201370.","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"1","key":"4870_CR156","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01808-1","volume":"9","author":"Y Xia","year":"2024","unstructured":"Xia Y, Sun M, Huang H, et al. Drug repurposing for cancer therapy. Signal Transduct Target Ther. 2024;9(1):92.","journal-title":"Signal Transduct Target Ther"},{"key":"4870_CR157","first-page":"305","volume":"10","author":"M Mu\u00f1oz","year":"2010","unstructured":"Mu\u00f1oz M, Cove\u00f1as R. Neurokinin-1 receptor: a new promising target in the treatment of cancer. Discov Med. 2010;10:305\u201313.","journal-title":"Discov Med"},{"key":"4870_CR158","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/j.apsb.2025.02.040","volume":"15","author":"L Zou","year":"2025","unstructured":"Zou L, Xian P, Pu Q, et al. Nano-drug delivery strategies affecting cancer-associated fibroblasts to reduce tumor metastasis. Acta Pharm Sin B. 2025;15:1841\u201368.","journal-title":"Acta Pharm Sin B"},{"key":"4870_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116042","volume":"44","author":"KT Kines","year":"2025","unstructured":"Kines KT, Fairchild HR, Elder AM, et al. Aging-induced semaphorin 7a promotes tgf-\u03b21-mediated cell plasticity and breast tumor metastases. Cell Rep. 2025;44:116042.","journal-title":"Cell Rep"},{"key":"4870_CR160","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2174\/1389557519666191112152642","volume":"20","author":"M Mu\u00f1oz","year":"2020","unstructured":"Mu\u00f1oz M, Rosso M, Cove\u00f1as R. Triple negative breast cancer: how neurokinin-1 receptor antagonists could be used as a new therapeutic approach. Mini-Rev Med Chem. 2020;20:408\u201317.","journal-title":"Mini-Rev Med Chem"},{"key":"4870_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114410","volume":"161","author":"Y Yang","year":"2023","unstructured":"Yang Y, Ren L, Li W, et al. Gabaergic signaling as a potential therapeutic target in cancers. Biomed Pharmacother. 2023;161:114410.","journal-title":"Biomed Pharmacother"},{"issue":"16","key":"4870_CR162","doi-asserted-by":"publisher","first-page":"6336","DOI":"10.1021\/jm5018913","volume":"58","author":"KM Brown","year":"2015","unstructured":"Brown KM, Roy KK, Hockerman GH, et al. Activation of the \u03b3-aminobutyric acid type b (gaba(b)) receptor by agonists and positive allosteric modulators. J Med Chem. 2015;58(16):6336\u201347.","journal-title":"J Med Chem"},{"key":"4870_CR163","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202504778","volume":"21","author":"L Zhang","year":"2025","unstructured":"Zhang L, Diao Q, Li B, et al. Delivery system of nanozymes loaded with dnazymes and hypoxia-activated prodrug for anti-tumor metastasis. Small. 2025;21:e2504778.","journal-title":"Small"},{"issue":"16","key":"4870_CR164","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1158\/1078-0432.CCR-22-3971","volume":"29","author":"L Shi","year":"2023","unstructured":"Shi L, Chen H, Chen K, et al. The drd2 antagonist haloperidol mediates autophagy-induced ferroptosis to increase temozolomide sensitivity by promoting endoplasmic reticulum stress in glioblastoma. Clin Cancer Res Off J Am Assoc Cancer Res. 2023;29(16):3172\u201388.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"4870_CR165","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-025-02249-0","volume":"10","author":"C Lee","year":"2025","unstructured":"Lee C, Kim M-J, Kumar A, et al. Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives. Signal Transduct Target Ther. 2025;10:170.","journal-title":"Signal Transduct Target Ther"},{"key":"4870_CR166","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/s41467-025-56690-4","volume":"16","author":"JL Cummings","year":"2025","unstructured":"Cummings JL, Zhou Y, Van Stone A, et al. Drug repurposing for alzheimer\u2019s disease and other neurodegenerative disorders. Nat Commun. 2025;16:1755.","journal-title":"Nat Commun"},{"key":"4870_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117535","volume":"290","author":"S Imtiaz","year":"2025","unstructured":"Imtiaz S, Ferdous UT, Nizela A, et al. Mechanistic study of cancer drug delivery: current techniques, limitations, and future prospects. Eur J Med Chem. 2025;290:117535.","journal-title":"Eur J Med Chem"},{"key":"4870_CR168","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13753","volume":"58","author":"L Gao","year":"2025","unstructured":"Gao L, Gao L, Huang S, et al. Nanoemulsion-based transdermal delivery of third-generation steroidal and non-steroidal aromatase inhibitors in preclinical models. Cell Prolif. 2025;58:e13753.","journal-title":"Cell Prolif"},{"key":"4870_CR169","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1158\/0008-5472.CAN-23-2654","volume":"85","author":"IE Elkholi","year":"2025","unstructured":"Elkholi IE, Robert A, Malouf C, et al. Targeting the dependence on pik3c3-mtorc1 signaling in dormancy-prone breast cancer cells blunts metastasis initiation. Cancer Res. 2025;85:2179\u201398.","journal-title":"Cancer Res"},{"key":"4870_CR170","doi-asserted-by":"publisher","first-page":"786","DOI":"10.21037\/jgo-2025-102","volume":"16","author":"M Sundbom","year":"2025","unstructured":"Sundbom M. Potential metastatic mechanisms and clinical aspects in patients with non-gastrointestinal tumor metastasis to the upper gastrointestinal tract. J Gastrointest Oncol. 2025;16:786\u201390.","journal-title":"J Gastrointest Oncol"},{"key":"4870_CR171","doi-asserted-by":"publisher","DOI":"10.1002\/inmd.70073","author":"N Wu","year":"2025","unstructured":"Wu N, Ma S, Liu X, et al. TROP2-guided aggregation-induced emission-luminogen nanoparticles overcome sacituzumab govitecan resistance via mitochondrial oxidative stress and immunogenic cell death in triple-negative breast cancer. Interdiscip Med. 2025;3:e70073.","journal-title":"Interdiscip Med"},{"key":"4870_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntm.2026.100115","volume":"5","author":"Y Wu","year":"2026","unstructured":"Wu Y, Liang J, Liang Y, et al. Unveiling the frontiers of self-assembled chinese herbal medicines nanodrugs in cancer therapy: a comprehensive bibliometric analysis and insights into emerging vesicle-based strategies. Nano TransMed. 2026;5:100115.","journal-title":"Nano TransMed"},{"key":"4870_CR173","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12943-025-02235-8","volume":"24","author":"T Cheytan","year":"2025","unstructured":"Cheytan T, Schneider M, W\u00fcrth R, et al. Small extracellular vesicles and particles (sevps) derived from tumor-free pre-metastatic organs promote breast cancer metastasis and support organotropism. Mol Cancer. 2025;24:72.","journal-title":"Mol Cancer"},{"key":"4870_CR174","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/COC.0000000000001177","volume":"48","author":"Z Qureshi","year":"2025","unstructured":"Qureshi Z, Altaf F, Jamil A, et al. Unlocking the mysteries of breast cancer: the role of epigenetics in diagnosis, treatment, and beyond. Am J Clin Oncol. 2025;48:276\u201382.","journal-title":"Am J Clin Oncol"},{"key":"4870_CR175","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1094-8","volume":"9","author":"N Pillar","year":"2018","unstructured":"Pillar N, Polsky AL, Weissglas-Volkov D, et al. Comparison of breast cancer metastasis models reveals a possible mechanism of tumor aggressiveness. Cell Death Dis. 2018;9:1040.","journal-title":"Cell Death Dis"},{"key":"4870_CR176","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2174\/0113862073376243250130060239","volume":"29","author":"J Mi","year":"2025","unstructured":"Mi J, Guo J, Kang K, et al. Advances in targeting neutrophil extracellular traps as a promising approach for breast cancer treatment. Comb Chem High Throughput Screen. 2025;29:9\u201319.","journal-title":"Comb Chem High Throughput Screen"},{"key":"4870_CR177","doi-asserted-by":"publisher","first-page":"6600","DOI":"10.1021\/acs.jmedchem.9b01810","volume":"63","author":"GM Dubowchik","year":"2020","unstructured":"Dubowchik GM, Conway CM, Xin AW. Blocking the cgrp pathway for acute and preventive treatment of migraine: the evolution of success. J Med Chem. 2020;63:6600\u201323.","journal-title":"J Med Chem"},{"key":"4870_CR178","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70220","volume":"97","author":"R Nabi","year":"2025","unstructured":"Nabi R, Chouljenko VN, Musarrat F, et al. The novel oncolytic herpes simplex virus type-1 (hsv-1) vaccine strain vc2 constitutively expressing gm-csf causes increased intratumoral t cell infiltration and inhibition of tumor metastasis in the 4t1\/balb\/c mouse model of stage four breast cancer. J Med Virol. 2025;97:e70220.","journal-title":"J Med Virol"},{"key":"4870_CR179","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10585-025-10332-7","volume":"42","author":"M Kunc","year":"2025","unstructured":"Kunc M, Skrzypkowska P, P\u0119ksa R, et al. Tumor-to-tumor metastases: systematic review and meta-analysis of 685 reported cases. Clin Exp Metastasis. 2025;42:14.","journal-title":"Clin Exp Metastasis"},{"key":"4870_CR180","first-page":"29","volume":"8","author":"P Xing","year":"2025","unstructured":"Xing P, Yang C, Hu H, et al. Antibody-drug conjugates in breast cancer: current resistance mechanisms and future combination strategies. Cancer Drug Resist. 2025;8:29.","journal-title":"Cancer Drug Resist"},{"key":"4870_CR181","volume":"71","author":"MN T\u00fcmkaya","year":"2025","unstructured":"T\u00fcmkaya MN, \u015een \u015e, Ero\u011flu K. Development and validation of the breast cancer myths scale for women. Rev Assoc Medica Bras 1992. 2025;71:e20241627.","journal-title":"Rev Assoc Medica Bras 1992"},{"key":"4870_CR182","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70059","volume":"6","author":"A Gu","year":"2025","unstructured":"Gu A, Li J, Li M-Y, et al. Patient-derived xenograft model in cancer: establishment and applications. MedComm. 2025;6:e70059.","journal-title":"MedComm"},{"key":"4870_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116683","volume":"231","author":"A Balkrishna","year":"2025","unstructured":"Balkrishna A, Mittal R, Bishayee A, et al. MiRNA signatures affecting the survival outcome in distant metastasis of triple-negative breast cancer. Biochem Pharmacol. 2025;231:116683.","journal-title":"Biochem Pharmacol"},{"key":"4870_CR184","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202417592","volume":"64","author":"Y Xie","year":"2025","unstructured":"Xie Y, Wang J, Li L, et al. A metal chelation therapy to effectively eliminate breast cancer and intratumor bacteria while suppressing tumor metastasis by copper depletion and zinc ions surge. Angew Chem Int Ed Engl. 2025;64:e202417592.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4870_CR185","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00262-004-0654-1","volume":"54","author":"Y-F He","year":"2005","unstructured":"He Y-F, Wang X-H, Zhang G-M, et al. Sustained low-level expression of interferon-\u03b3 promotes tumor development: potential insights in tumor prevention and tumor immunotherapy. Cancer Immunol Immunother CII. 2005;54:891\u20137.","journal-title":"Cancer Immunol Immunother CII"},{"key":"4870_CR186","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/MOO.0b013e32833bb16f","volume":"18","author":"MG Sardesai","year":"2010","unstructured":"Sardesai MG, Moe K. Recent progress in facial paralysis: advances and obstacles. Curr Opin Otolaryngol Head Neck Surg. 2010;18:266\u201371.","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"4870_CR187","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/med4.51","volume":"2","author":"R Sharma","year":"2024","unstructured":"Sharma R, Malviya R. Modifying the electrical, optical, and magnetic properties of cancer cells: a comprehensive approach for cancer management. Med Adv. 2024;2:3\u201319.","journal-title":"Med Adv"},{"key":"4870_CR188","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/s41590-024-02015-4","volume":"25","author":"S Goswami","year":"2024","unstructured":"Goswami S, Pauken KE, Wang L, et al. Next-generation combination approaches for immune checkpoint therapy. Nat Immunol. 2024;25:2186\u201399.","journal-title":"Nat Immunol"},{"key":"4870_CR189","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/j.clbc.2024.09.015","volume":"25","author":"F Shen","year":"2025","unstructured":"Shen F, Liu Q, Wang Y, et al. Comparison of [(18)f] fdg pet\/ct and [(18)f]fdg pet\/mri in the detection of distant metastases in breast cancer: a meta-analysis. Clin Breast Cancer. 2025;25:e113-e123.e4.","journal-title":"Clin Breast Cancer"},{"key":"4870_CR190","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12935-024-03505-z","volume":"24","author":"G Wang","year":"2024","unstructured":"Wang G, Shi C, He L, et al. Identification of the tumor metastasis-related tumor subgroups overexpressed nenf in triple-negative breast cancer by single-cell transcriptomics. Cancer Cell Int. 2024;24:319.","journal-title":"Cancer Cell Int"},{"key":"4870_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114941","volume":"159","author":"L Liu","year":"2025","unstructured":"Liu L, Lou S, Fu D, et al. Neuro-immune interactions: exploring the anti-inflammatory role of the vagus nerve. Int Immunopharmacol. 2025;159:114941.","journal-title":"Int Immunopharmacol"},{"key":"4870_CR192","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47020122","author":"Z Chen","year":"2025","unstructured":"Chen Z, Liu K. Mechanism and applications of vagus nerve stimulation. Curr Issues Mol Biol. 2025;47:122.","journal-title":"Curr Issues Mol Biol"},{"key":"4870_CR193","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117430","volume":"179","author":"R Ni","year":"2024","unstructured":"Ni R, Hu Z, Tao R. Advances of immune-checkpoint inhibition of ctla-4 in pancreatic cancer. Biomed Pharmacother. 2024;179:117430.","journal-title":"Biomed Pharmacother"},{"key":"4870_CR194","volume":"5","author":"Y Niu","year":"2025","unstructured":"Niu Y, Feng J, Ma J, et al. Targeting the tumor microbiota in cancer therapy basing on nanomaterials. Explor Beijing China. 2025;5:e20210185.","journal-title":"Explor Beijing China"},{"key":"4870_CR195","unstructured":"Lin A, Xiong M, Jiang A, et al. The microbiome in cancer. iMeta. 2025;4:e70070."},{"key":"4870_CR196","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41522-025-00678-x","volume":"11","author":"J Sun","year":"2025","unstructured":"Sun J, Song S, Liu J, et al. Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation. Npj Biofilms Microbiomes. 2025;11:43.","journal-title":"Npj Biofilms Microbiomes"},{"key":"4870_CR197","doi-asserted-by":"publisher","unstructured":"Mahomoodally MF, Kowlessur E, Venugopala KN, et al. In Vitro Mechanistic Insights into Traditionally Consumed Food Plants for Breast Cancer Management. J Future Foods. 2026. https:\/\/doi.org\/10.1016\/j.jfutfo.2025.09.002.","DOI":"10.1016\/j.jfutfo.2025.09.002"},{"key":"4870_CR198","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00432-024-05807-1","volume":"150","author":"L Zhang","year":"2024","unstructured":"Zhang L, Huang S, Yuan Y. Butyrate inhibits the malignant biological behaviors of breast cancer cells by facilitating cuproptosis-associated gene expression. J Cancer Res Clin Oncol. 2024;150:287.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4870_CR199","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s42255-024-01191-9","volume":"7","author":"M Nshanian","year":"2025","unstructured":"Nshanian M, Gruber JJ, Geller BS, et al. Short-chain fatty acid metabolites propionate and butyrate are unique epigenetic regulatory elements linking diet, metabolism and gene expression. Nat Metab. 2025;7:196\u2013211.","journal-title":"Nat Metab"},{"key":"4870_CR200","doi-asserted-by":"publisher","first-page":"8778","DOI":"10.1038\/s41598-025-92125-2","volume":"15","author":"C Segui-Perez","year":"2025","unstructured":"Segui-Perez C, Huang LZX, Paganelli FL, et al. Probiotic bifidobacterium bifidum strains desialylate muc13 and increase intestinal epithelial barrier function. Sci Rep. 2025;15:8778.","journal-title":"Sci Rep"},{"key":"4870_CR201","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1053\/j.gastro.2021.08.047","volume":"161","author":"W-T Kuo","year":"2021","unstructured":"Kuo W-T, Zuo L, Odenwald MA, et al. The tight junction protein zo-1 is dispensable for barrier function but critical for effective mucosal repair. Gastroenterology. 2021;161:1924\u201339.","journal-title":"Gastroenterology"},{"key":"4870_CR202","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.132730","volume":"274","author":"P Sengupta","year":"2024","unstructured":"Sengupta P, Roy A, Roy L, et al. Long non-coding intergenic rna, linc00273 induces cancer metastasis and stemness via mirna sponging in triple negative breast cancer. Int J Biol Macromol. 2024;274:132730.","journal-title":"Int J Biol Macromol"},{"key":"4870_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.150974","volume":"739","author":"M-N Li","year":"2024","unstructured":"Li M-N, Han Q, Wang N, et al. 16S rrna gene sequencing for bacterial identification and infectious disease diagnosis. Biochem Biophys Res Commun. 2024;739:150974.","journal-title":"Biochem Biophys Res Commun"},{"key":"4870_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101982","volume":"6","author":"KJ O\u2019Riordan","year":"2025","unstructured":"O\u2019Riordan KJ, Moloney GM, Keane L, et al. The gut microbiota-immune-brain axis: therapeutic implications. Cell Rep Med. 2025;6:101982.","journal-title":"Cell Rep Med"},{"key":"4870_CR205","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj5435","volume":"7","author":"M Kaduri","year":"2021","unstructured":"Kaduri M, Sela M, Kagan S, et al. Targeting neurons in the tumor microenvironment with bupivacaine nanoparticles reduces breast cancer progression and metastases. Sci Adv. 2021;7:eabj5435.","journal-title":"Sci Adv"},{"key":"4870_CR206","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122697","volume":"348","author":"N Shukla","year":"2024","unstructured":"Shukla N, Shah K, Rathore D, et al. Androgen receptor: structure, signaling, function and potential drug discovery biomarker in different breast cancer subtypes. Life Sci. 2024;348:122697.","journal-title":"Life Sci"},{"key":"4870_CR207","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.molonc.2015.05.001","volume":"9","author":"J Pundavela","year":"2015","unstructured":"Pundavela J, Roselli S, Faulkner S, et al. Nerve fibers infiltrate the tumor microenvironment and are associated with nerve growth factor production and lymph node invasion in breast cancer. Mol Oncol. 2015;9:1626\u201335.","journal-title":"Mol Oncol"},{"key":"4870_CR208","volume":"1878","author":"J Li","year":"2023","unstructured":"Li J, Che M, Zhang B, et al. The association between the neuroendocrine system and the tumor immune microenvironment: emerging directions for cancer immunotherapy. Biochimica et Biophysica Acta (BBA). 2023;1878:189007.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"4870_CR209","doi-asserted-by":"publisher","first-page":"295","DOI":"10.5483\/BMBRep.2015.48.5.008","volume":"48","author":"J Qin","year":"2015","unstructured":"Qin J, Jin F, Li N, et al. Adrenergic receptor \u03b22 activation by stress promotes breast cancer progression through macrophages m2 polarization in tumor microenvironment. BMB Rep. 2015;48:295\u2013300.","journal-title":"BMB Rep"},{"key":"4870_CR210","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41556-021-00820-9","volume":"24","author":"D Huang","year":"2022","unstructured":"Huang D, Wang Y, Thompson JW, et al. Cancer-cell-derived gaba promotes \u03b2-catenin-mediated tumour growth and immunosuppression. Nat Cell Biol. 2022;24:230\u201341.","journal-title":"Nat Cell Biol"},{"key":"4870_CR211","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","volume":"24","author":"MA Harris","year":"2024","unstructured":"Harris MA, Savas P, Virassamy B, et al. Towards targeting the breast cancer immune microenvironment. Nat Rev Cancer. 2024;24:554\u201377.","journal-title":"Nat Rev Cancer"},{"key":"4870_CR212","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-024-01778-w","volume":"26","author":"J Qian","year":"2024","unstructured":"Qian J, Ma Y, Tahaney WM, et al. The novel phosphatase nudt5 is a critical regulator of triple-negative breast cancer growth. Breast Cancer Res. 2024;26:23.","journal-title":"Breast Cancer Res"},{"key":"4870_CR213","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12020369","author":"SS Said","year":"2024","unstructured":"Said SS, Ibrahim WN. Breaking barriers: the promise and challenges of immune checkpoint inhibitors in triple-negative breast cancer. Biomedicines. 2024;12:369.","journal-title":"Biomedicines"},{"key":"4870_CR214","doi-asserted-by":"publisher","first-page":"1","DOI":"10.20892\/j.issn.2095-3941.2024.0510","volume":"22","author":"J Bai","year":"2025","unstructured":"Bai J, Gao Y, Zhang G. The treatment of breast cancer in the era of precision medicine. Cancer Biol Med. 2025;22:1\u201326.","journal-title":"Cancer Biol Med"},{"key":"4870_CR215","doi-asserted-by":"crossref","unstructured":"Cejalvo And\u00fajar JM, Ayala de la Pe\u00f1a F, Margeli Vila M, et al. Optimizing therapeutic approaches for hr+\/her2- advanced breast cancer: clinical perspectives on biomarkers and treatment strategies post-cdk4\/6 inhibitor progression. Cancer Drug Resist. Alhambra Calif 2025;8:5.","DOI":"10.20517\/cdr.2024.169"},{"key":"4870_CR216","doi-asserted-by":"publisher","DOI":"10.1016\/j.curpro.2025.100055","volume":"22","author":"M-Y Li","year":"2025","unstructured":"Li M-Y, Zhang Q, Zengin G, et al. Spatial omics: deciphering heterogeneity in the tumor immune microenvironment and resistance to immunotherapy. Curr Proteomics. 2025;22:100055.","journal-title":"Curr Proteomics"},{"key":"4870_CR217","first-page":"36","volume":"8","author":"S Saha","year":"2025","unstructured":"Saha S, Mahapatra S, Khanra S, et al. Decoding breast cancer treatment resistance through genetic, epigenetic, and immune-regulatory mechanisms: from molecular insights to translational perspectives. Cancer Drug Resist. 2025;8:36.","journal-title":"Cancer Drug Resist"},{"key":"4870_CR218","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.70119","volume":"59","author":"X Zhao","year":"2026","unstructured":"Zhao X, Qiu Y, Chen J, et al. Non-coding rnas in breast cancer radioresistance: mechanisms, functional roles and translational potentials. Cell Prolif. 2026;59:e70119.","journal-title":"Cell Prolif"},{"key":"4870_CR219","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/mdb2.70009","volume":"1","author":"X Che","year":"2025","unstructured":"Che X, Wang H, Wang H, et al. Intratumoral nerve phased development: a promising therapeutic target. Med Bull. 2025;1:154\u201370.","journal-title":"Med Bull"},{"key":"4870_CR220","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41573-024-01017-z","volume":"23","author":"D Yaniv","year":"2024","unstructured":"Yaniv D, Mattson B, Talbot S, et al. Targeting the peripheral neural-tumour microenvironment for cancer therapy. Nat Rev Drug Discov. 2024;23:780\u201396.","journal-title":"Nat Rev Drug Discov"},{"key":"4870_CR221","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081979","author":"JH Baraldi","year":"2022","unstructured":"Baraldi JH, Martyn GV, Shurin GV, et al. Tumor innervation: history, methodologies, and significance. Cancers. 2022;14:1979.","journal-title":"Cancers"},{"key":"4870_CR222","doi-asserted-by":"publisher","first-page":"89","DOI":"10.21037\/atm.2018.01.01","volume":"6","author":"M Arese","year":"2018","unstructured":"Arese M, Bussolino F, Pergolizzi M, et al. Tumor progression: the neuronal input. Ann Transl Med. 2018;6:89\u201389.","journal-title":"Ann Transl Med"},{"key":"4870_CR223","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01955-5","volume":"9","author":"Z Liu","year":"2024","unstructured":"Liu Z, Chen J, Ren Y, et al. Multi-stage mechanisms of tumor metastasis and therapeutic strategies. Signal Transduct Target Ther. 2024;9:270.","journal-title":"Signal Transduct Target Ther"},{"key":"4870_CR224","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10555-013-9440-x","volume":"32","author":"M Shi","year":"2013","unstructured":"Shi M, Liu D, Yang Z, et al. Central and peripheral nervous systems: master controllers in cancer metastasis. Cancer Metastasis Rev. 2013;32:603\u201321.","journal-title":"Cancer Metastasis Rev"},{"key":"4870_CR225","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/ijc.35421","volume":"157","author":"T Huang","year":"2025","unstructured":"Huang T, Wu D, Jiang L, et al. Neuro\u2013astrocytic network in breast cancer brain metastases: adaptive mechanisms and novel therapeutic targets. Int J Cancer. 2025;157:18\u201331.","journal-title":"Int J Cancer"},{"key":"4870_CR226","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10555-023-10095-1","volume":"42","author":"Q Cui","year":"2023","unstructured":"Cui Q, Jiang D, Zhang Y, et al. The tumor-nerve circuit in breast cancer. Cancer Metastasis Rev. 2023;42:543\u201374.","journal-title":"Cancer Metastasis Rev"},{"key":"4870_CR227","volume":"10","author":"J Wu","year":"2025","unstructured":"Wu J, Lu X, Yan C. Neuro-immune-cancer interactions: mechanisms and therapeutic implications for tumor modulation. Brain Behav Immun Integr. 2025;10:100119.","journal-title":"Brain Behav Immun Integr"},{"key":"4870_CR228","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.7150\/thno.81403","volume":"13","author":"RQ Li","year":"2023","unstructured":"Li RQ, Zhao XH, Zhu Q, et al. Exploring neurotransmitters and their receptors for breast cancer prevention and treatment. Theranostics. 2023;13:1109\u201329.","journal-title":"Theranostics"},{"key":"4870_CR229","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172499","volume":"859","author":"L Yang","year":"2019","unstructured":"Yang L, Yao Y, Yong L, et al. Dopamine d1 receptor agonists inhibit lung metastasis of breast cancer reducing cancer stemness. Eur J Pharmacol. 2019;859:172499.","journal-title":"Eur J Pharmacol"},{"key":"4870_CR230","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10549-019-05341-6","volume":"177","author":"S Kurozumi","year":"2019","unstructured":"Kurozumi S, Kaira K, Matsumoto H, et al. \u03922-adrenergic receptor expression is associated with biomarkers of tumor immunity and predicts poor prognosis in estrogen receptor-negative breast cancer. Breast Cancer Res Treat. 2019;177:603\u201310.","journal-title":"Breast Cancer Res Treat"},{"key":"4870_CR231","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2021.102159","volume":"89","author":"M Levite","year":"2021","unstructured":"Levite M, Safadi R, Milgrom Y, et al. Neurotransmitters and neuropeptides decrease pd-1 in t cells of healthy subjects and patients with hepatocellular carcinoma (hcc), and increase their proliferation and eradication of hcc cells. Neuropeptides. 2021;89:102159.","journal-title":"Neuropeptides"},{"key":"4870_CR232","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/apha.12476","volume":"216","author":"M Levite","year":"2015","unstructured":"Levite M. Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases. Acta Physiol. 2015;216:42\u201389.","journal-title":"Acta Physiol"},{"key":"4870_CR233","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155180","volume":"123","author":"C Yang","year":"2024","unstructured":"Yang C, Qian C, Zheng W, et al. Ginsenoside rh2 enhances immune surveillance of natural killer (nk) cells via inhibition of erp5 in breast cancer. Phytomedicine. 2024;123:155180.","journal-title":"Phytomedicine"},{"key":"4870_CR234","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/0952-8180(88)90014-1","volume":"1","author":"LI Goldberg","year":"1988","unstructured":"Goldberg LI. Dopamine and new dopamine analogs: receptors and clinical applications. J Clin Anesth. 1988;1:66\u201374.","journal-title":"J Clin Anesth"},{"key":"4870_CR235","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0002-9394(02)01699-9","volume":"134","author":"PJ Lama","year":"2002","unstructured":"Lama PJ. Systemic adverse effects of beta-adrenergic blockers: an evidence-based assessment. Am J Ophthalmol. 2002;134:749\u201360.","journal-title":"Am J Ophthalmol"},{"key":"4870_CR236","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1474-8673.1982.tb00489.x","volume":"2","author":"MF Lokhandwala","year":"1982","unstructured":"Lokhandwala MF, Barrett RJ. Cardiovascular dopamine receptors: physiological, pharmacological and therapeutic implications. J Auton Pharmacol. 1982;2:189\u2013215.","journal-title":"J Auton Pharmacol"},{"key":"4870_CR237","doi-asserted-by":"crossref","first-page":"H351","DOI":"10.1152\/ajpcell.1984.246.3.C351","volume":"246","author":"D Gustafsson","year":"1984","unstructured":"Gustafsson D, Lundvall J. Beta 2-adrenergic vascular control in hemorrhage and its influence on cardiac performance. Am J Physiol. 1984;246:H351-359.","journal-title":"Am J Physiol"},{"key":"4870_CR238","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/0002-8703(91)90612-L","volume":"121","author":"RG Shanks","year":"1991","unstructured":"Shanks RG. Clinical pharmacology of vasodilatory beta-blocking drugs. Am Heart J. 1991;121:1006\u201311.","journal-title":"Am Heart J"},{"key":"4870_CR239","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0006-8993(94)91368-4","volume":"656","author":"RF Kirby","year":"1994","unstructured":"Kirby RF, Novak CM, Thunhorst RL, et al. The role of beta1 and beta2 adrenoceptors in isoproterenol-induced drinking. Brain Res. 1994;656:79\u201384.","journal-title":"Brain Res"},{"key":"4870_CR240","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s002130050675","volume":"138","author":"AH van Stegeren","year":"1998","unstructured":"van Stegeren AH, Everaerd W, Cahill L. Memory for emotional events: differential effects of centrally versus peripherally acting beta-blocking agents. Psychopharmacology (Berl). 1998;138:305\u201310.","journal-title":"Psychopharmacology (Berl.)"},{"key":"4870_CR241","doi-asserted-by":"publisher","first-page":"13626","DOI":"10.1073\/pnas.1635116100","volume":"100","author":"BA Strange","year":"2003","unstructured":"Strange BA, Hurlemann R, Dolan RJ. An emotion-induced retrograde amnesia in humans is amygdala- and beta-adrenergic-dependent. Proc Natl Acad Sci U S A. 2003;100:13626\u201331.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4870_CR242","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108750","volume":"264","author":"Z-K Dong","year":"2024","unstructured":"Dong Z-K, Wang Y-F, Li W-P, et al. Neurobiology of cancer: adrenergic signaling and drug repurposing. Pharmacol Ther. 2024;264:108750.","journal-title":"Pharmacol Ther"},{"key":"4870_CR243","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/s41416-022-01891-7","volume":"127","author":"LL L\u00f8fling","year":"2022","unstructured":"L\u00f8fling LL, St\u00f8er NC, Sloan EK, et al. \u03b2-blockers and breast cancer survival by molecular subtypes: a population-based cohort study and meta-analysis. Br J Cancer. 2022;127:1086\u201396.","journal-title":"Br J Cancer"},{"key":"4870_CR244","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.3892\/or.2016.4710","volume":"35","author":"C Choy","year":"2016","unstructured":"Choy C, Raytis JL, Smith DD, et al. Inhibition of \u03b22-adrenergic receptor reduces triple-negative breast cancer brain metastases: the potential benefit of perioperative \u03b2-blockade. Oncol Rep. 2016;35:3135\u201342.","journal-title":"Oncol Rep"},{"key":"4870_CR245","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1200\/JCO.2010.33.4441","volume":"29","author":"A Melhem-Bertrandt","year":"2011","unstructured":"Melhem-Bertrandt A, Chavez-MacGregor M, Lei X, et al. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol. 2011;29:2645\u201352.","journal-title":"J Clin Oncol"},{"key":"4870_CR246","doi-asserted-by":"publisher","first-page":"797","DOI":"10.18632\/oncotarget.343","volume":"2","author":"E Pasquier","year":"2011","unstructured":"Pasquier E, Ciccolini J, Carre M, et al. Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment. Oncotarget. 2011;2:797\u2013809.","journal-title":"Oncotarget"},{"key":"4870_CR247","doi-asserted-by":"publisher","first-page":"L521","DOI":"10.1152\/ajplung.00287.2009","volume":"298","author":"EA Townsend","year":"2010","unstructured":"Townsend EA, Thompson MA, Pabelick CM, et al. Rapid effects of estrogen on intracellular ca2+ regulation in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2010;298:L521-30.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4870_CR248","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009912","volume":"18","author":"F Mahmood","year":"2022","unstructured":"Mahmood F, Astono IP, Welsh JS, et al. Objective quantification of nerves in immunohistochemistry specimens of thyroid cancer utilising deep learning. PLoS Comput Biol. 2022;18:e1009912.","journal-title":"PLoS Comput Biol"},{"key":"4870_CR249","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/nan.12651","volume":"47","author":"G Piscosquito","year":"2020","unstructured":"Piscosquito G, Provitera V, Mozzillo S, et al. The analysis of epidermal nerve fibre spatial distribution improves the diagnostic yield of skin biopsy. Neuropathol Appl Neurobiol. 2020;47:210\u20137.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"4870_CR250","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2023.111228","volume":"166","author":"Q Yang","year":"2024","unstructured":"Yang Q, Yang Z, Cai X, et al. Advances in methodologies of negative controls: a scoping review. J Clin Epidemiol. 2024;166:111228.","journal-title":"J Clin Epidemiol"},{"key":"4870_CR251","doi-asserted-by":"publisher","DOI":"10.3390\/biom13040622","author":"F Concei\u00e7\u00e3o","year":"2023","unstructured":"Concei\u00e7\u00e3o F, Sousa DM, Tojal S, et al. The secretome of parental and bone metastatic breast cancer elicits distinct effects in human osteoclast activity after activation of \u03b22 adrenergic signaling. Biomolecules. 2023;13:622.","journal-title":"Biomolecules"},{"key":"4870_CR252","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106025","volume":"26","author":"S Subedi","year":"2023","unstructured":"Subedi S, Park YP. Single-cell pair-wise relationships untangled by composite embedding model. iScience. 2023;26:106025.","journal-title":"iScience"},{"key":"4870_CR253","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41523-023-00527-0","volume":"9","author":"D Zhou","year":"2023","unstructured":"Zhou D, Li M, Yasin MH, et al. The prognostic value and immune microenvironment association of ar in her2+ nonmetastatic breast cancer. Npj Breast Cancer. 2023;9:30.","journal-title":"Npj Breast Cancer"},{"key":"4870_CR254","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1111\/bcp.14030","volume":"85","author":"EM Rivero","year":"2019","unstructured":"Rivero EM, Martinez LM, Bruque CD, et al. Prognostic significance of \u03b1- and \u03b22-adrenoceptor gene expression in breast cancer patients. Br J Clin Pharmacol. 2019;85:2143\u201354.","journal-title":"Br J Clin Pharmacol"},{"key":"4870_CR255","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41568-025-00831-w","volume":"25","author":"M Amit","year":"2025","unstructured":"Amit M, Eichwald T, Roger A, et al. Neuro-immune cross-talk in cancer. Nat Rev Cancer. 2025;25:573\u201389.","journal-title":"Nat Rev Cancer"},{"key":"4870_CR256","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1007\/s00262-023-03445-z","volume":"72","author":"S Thapa","year":"2023","unstructured":"Thapa S, Cao X. Nervous regulation: beta-2-adrenergic signaling in immune homeostasis, cancer immunotherapy, and autoimmune diseases. Cancer Immunol Immunother. 2023;72:2549\u201356.","journal-title":"Cancer Immunol Immunother"},{"key":"4870_CR257","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1172\/JCI129502","volume":"129","author":"H Mohammadpour","year":"2019","unstructured":"Mohammadpour H, MacDonald CR, Qiao G, et al. \u03922 adrenergic receptor\u2013mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells. J Clin Invest. 2019;129:5537\u201352.","journal-title":"J Clin Invest"},{"key":"4870_CR258","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/s41467-020-15676-0","volume":"11","author":"M Chen","year":"2020","unstructured":"Chen M, Qiao G, Hylander BL, et al. Adrenergic stress constrains the development of anti-tumor immunity and abscopal responses following local radiation. Nat Commun. 2020;11:1821.","journal-title":"Nat Commun"},{"key":"4870_CR259","doi-asserted-by":"publisher","DOI":"10.1002\/INMD.20240058","author":"Q-X Gao","year":"2025","unstructured":"Gao Q-X, Wu Q-Q, Dong Z-Y, et al. In situ detection of pirna-651 in exosomes and cells for cancer diagnosis by a new gold nanoparticle nucleic acid probe. Interdiscip Med. 2025;3:e20240058.","journal-title":"Interdiscip Med"},{"key":"4870_CR260","first-page":"20240259","volume":"6","author":"T Zhao","year":"2026","unstructured":"Zhao T, Chen Y, Yuan H, et al. One-stone-two-birds carrier-free nano-cocktail enables synergistic eradication of cancer cells\/stem cells in breast cancer treatment. Explor Beijing China. 2026;6:20240259.","journal-title":"Explor Beijing China"},{"key":"4870_CR261","doi-asserted-by":"crossref","unstructured":"Liu T, Huang T, Ding T, et al. Leveraging multi-modal foundation models for analysing spatial multi-omic and histopathology data. Nat Biomed Eng. 2026;4:e01602.","DOI":"10.1038\/s41551-025-01602-6"},{"key":"4870_CR262","doi-asserted-by":"publisher","first-page":"153535082412452","DOI":"10.1177\/15353508241245265","volume":"23","author":"SJ Archibald","year":"2024","unstructured":"Archibald SJ, Holland JP, Korde A, et al. Combining nuclear medicine with other modalities: future prospect for multimodality imaging. Mol Imaging. 2024;23:15353508241245264.","journal-title":"Mol Imaging"},{"key":"4870_CR263","doi-asserted-by":"publisher","first-page":"153535082412614","DOI":"10.1177\/15353508241261473","volume":"23","author":"L Zhang","year":"2024","unstructured":"Zhang L, Zhao L, Lin X, et al. Comparison of tumor non-specific and pd-l1 specific imaging by near-infrared fluorescence\/cerenkov luminescence dual-modality in-situ imaging. Mol Imaging. 2024;23:15353508241261472.","journal-title":"Mol Imaging"},{"key":"4870_CR264","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","volume":"9","author":"L Ma","year":"2024","unstructured":"Ma L, Guo H, Zhao Y, et al. Liquid biopsy in cancer current: status, challenges and future prospects. Signal Transduct Target Ther. 2024;9:336.","journal-title":"Signal Transduct Target Ther"},{"key":"4870_CR265","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1038\/s41467-020-17090-y","volume":"11","author":"R Ben-Hamo","year":"2020","unstructured":"Ben-Hamo R, Jacob Berger A, Gavert N, et al. Predicting and affecting response to cancer therapy based on pathway-level biomarkers. Nat Commun. 2020;11:3296.","journal-title":"Nat Commun"},{"key":"4870_CR266","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10120-024-01479-5","volume":"27","author":"P Morgagni","year":"2024","unstructured":"Morgagni P, Bencivenga M, Carneiro F, et al. International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape. Gastric Cancer. 2024;27:649\u201371.","journal-title":"Gastric Cancer"},{"key":"4870_CR267","doi-asserted-by":"crossref","unstructured":"Li J, Gu A, Tang N, et al. Patient-derived xenograft models in pan-cancer: from bench to clinic. Interdiscip Med. 2025;3:e2024015.","DOI":"10.1002\/INMD.20250016"},{"key":"4870_CR268","doi-asserted-by":"publisher","DOI":"10.3389\/or.2024.1435922","volume":"18","author":"Z Xu","year":"2024","unstructured":"Xu Z, Jiang G, Dai J. Tumor therapeutics in the era of \u201crecist\u201d: past, current insights, and future prospects. Oncol Rev. 2024;18:1435922.","journal-title":"Oncol Rev"},{"key":"4870_CR269","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2217\/imt-2023-0184","volume":"16","author":"T Kus","year":"2024","unstructured":"Kus T, Cicin I. A perspective: the integration of ctDNA into response evaluation criteria in solid tumours 1.1 for phase II immunotherapy clinical trials. Immunotherapy. 2024;16:319\u201329.","journal-title":"Immunotherapy"},{"key":"4870_CR270","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1177\/0284185119887588","volume":"61","author":"Y-C Lai","year":"2019","unstructured":"Lai Y-C, Chang W-C, Chen C-B, et al. Response evaluation for immunotherapy through semi-automatic software based on RECIST 1.1, irRC, and iRECIST criteria: comparison with subjective assessment. Acta Radiol. 2019;61:983\u201391.","journal-title":"Acta Radiol"},{"key":"4870_CR271","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","volume":"18","author":"L Seymour","year":"2017","unstructured":"Seymour L, Bogaerts J, Perrone A, et al. IRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol. 2017;18:e143\u201352.","journal-title":"Lancet Oncol"},{"key":"4870_CR272","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081999","author":"E Tzoras","year":"2022","unstructured":"Tzoras E, Zerdes I, Tsiknakis N, et al. Dissecting tumor-immune microenvironment in breast cancer at a spatial and multiplex resolution. Cancers. 2022;14:1999.","journal-title":"Cancers"},{"key":"4870_CR273","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1016\/j.neuron.2025.07.002","volume":"113","author":"H-Z Wen","year":"2025","unstructured":"Wen H-Z, Xiong S-Y, Lou Y-X, et al. Social interaction in mice suppresses breast cancer progression via a corticoamygdala neural circuit. Neuron. 2025;113:3374-3389.e9.","journal-title":"Neuron"},{"key":"4870_CR274","volume":"1877","author":"J Hu","year":"2022","unstructured":"Hu J, Chen W, Shen L, et al. Crosstalk between the peripheral nervous system and breast cancer influences tumor progression. Biochimica et Biophysica Acta (BBA). 2022;1877:188828.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"4870_CR275","volume":"1879","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Lv ZG, Lu M, et al. Nerve-tumor crosstalk in tumor microenvironment: from tumor initiation and progression to clinical implications. Biochimica et Biophysica Acta (BBA). 2024;1879:189121.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"4870_CR276","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00906","volume":"14","author":"CH Chung","year":"2020","unstructured":"Chung CH, Bretherton B, Zainalabidin S, et al. Mediation of cardiac macrophage activity via auricular vagal nerve stimulation ameliorates cardiac ischemia\/reperfusion injury. Front Neurosci. 2020;14:906.","journal-title":"Front Neurosci"},{"key":"4870_CR277","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1158\/2159-8290.CD-18-0046","volume":"8","author":"BW Renz","year":"2018","unstructured":"Renz BW, Tanaka T, Sunagawa M, et al. Cholinergic signaling via muscarinic receptors directly and indirectly suppresses pancreatic tumorigenesis and cancer stemness. Cancer Discov. 2018;8:1458\u201373.","journal-title":"Cancer Discov"},{"key":"4870_CR278","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.610303","volume":"11","author":"V Salemme","year":"2021","unstructured":"Salemme V, Centonze G, Cavallo F, et al. The crosstalk between tumor cells and the immune microenvironment in breast cancer: implications for immunotherapy. Front Oncol. 2021;11:610303.","journal-title":"Front Oncol"},{"key":"4870_CR279","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217132","volume":"598","author":"Y Liu","year":"2024","unstructured":"Liu Y, Yin S, Lu G, et al. The intersection of the nervous system and breast cancer. Cancer Lett. 2024;598:217132.","journal-title":"Cancer Lett"},{"key":"4870_CR280","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.ccell.2025.03.004","volume":"43","author":"Y Liu","year":"2025","unstructured":"Liu Y, Sinjab A, Min J, et al. Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics. Cancer Cell. 2025;43:905-924.e6.","journal-title":"Cancer Cell"},{"key":"4870_CR281","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00432-023-05599-w","volume":"150","author":"B Zheng","year":"2024","unstructured":"Zheng B, Du P, Zeng Z, et al. Propranolol inhibits emt and metastasis in breast cancer through mir-499-5p-mediated sox6. J Cancer Res Clin Oncol. 2024;150:59.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4870_CR282","first-page":"341","volume":"41","author":"W-Y Xie","year":"2018","unstructured":"Xie W-Y, He R-H, Zhang J, et al. \u0392-blockers inhibit the viability of breast cancer cells by regulating the erk\/cox-2 signaling pathway and the drug response is affected by adrb2 single-nucleotide polymorphisms. Oncol Rep. 2018;41:341\u201350.","journal-title":"Oncol Rep"},{"key":"4870_CR283","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174269","volume":"14","author":"R Takahashi","year":"2022","unstructured":"Takahashi R, Ijichi H, Fujishiro M. The role of neural signaling in the pancreatic cancer microenvironment. Cancers. 2022;14:289.","journal-title":"Cancers"},{"key":"4870_CR284","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1038\/s41388-021-01691-y","volume":"40","author":"R Wu","year":"2021","unstructured":"Wu R, Li K, Yuan M, et al. Nerve growth factor receptor increases the tumor growth and metastatic potential of triple-negative breast cancer cells. Oncogene. 2021;40:2165\u201381.","journal-title":"Oncogene"},{"key":"4870_CR285","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2174\/1568009623666230904150957","volume":"24","author":"Y Fan","year":"2024","unstructured":"Fan Y, Zhang B, Du X, et al. Regulating tumorigenicity and cancer metastasis through trka signaling. Curr Cancer Drug Targets. 2024;24:271\u201387.","journal-title":"Curr Cancer Drug Targets"},{"key":"4870_CR286","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.676568","volume":"9","author":"M Di Donato","year":"2021","unstructured":"Di Donato M, Galasso G, Giovannelli P, et al. Targeting the nerve growth factor signaling impairs the proliferative and migratory phenotype of triple-negative breast cancer cells. Front Cell Dev Biol. 2021;9:676568.","journal-title":"Front Cell Dev Biol"},{"key":"4870_CR287","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/1476-4598-9-157","volume":"9","author":"R Romon","year":"2010","unstructured":"Romon R, Adriaenssens E, Lagadec C, et al. Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways. Mol Cancer. 2010;9:157.","journal-title":"Mol Cancer"},{"key":"4870_CR288","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-023-06568-6","volume":"622","author":"A-M Globig","year":"2023","unstructured":"Globig A-M, Zhao S, Roginsky J, et al. The \u03b21-adrenergic receptor links sympathetic nerves to t cell exhaustion. Nature. 2023;622:383\u201392.","journal-title":"Nature"},{"key":"4870_CR289","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092682","volume":"12","author":"M Mu\u00f1oz","year":"2020","unstructured":"Mu\u00f1oz M, Cove\u00f1as R. The neurokinin-1 receptor antagonist aprepitant: an intelligent bullet against cancer? Cancers. 2020;12:295.","journal-title":"Cancers"},{"key":"4870_CR290","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13046-022-02314-4","volume":"41","author":"S Trouvilliez","year":"2022","unstructured":"Trouvilliez S, Cicero J, L\u00e9v\u00eaque R, et al. Direct interaction of trka\/cd44v3 is essential for ngf-promoted aggressiveness of breast cancer cells. J Exp Clin Cancer Res. 2022;41:110.","journal-title":"J Exp Clin Cancer Res"},{"key":"4870_CR291","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2023.02.011","volume":"110","author":"M Falcinelli","year":"2023","unstructured":"Falcinelli M, Al-Hity G, Baron S, et al. Propranolol reduces ifn-\u03b3 driven pd-l1 immunosuppression and improves anti-tumour immunity in ovarian cancer. Brain Behav Immun. 2023;110:1\u201312.","journal-title":"Brain Behav Immun"},{"key":"4870_CR292","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.bj.2019.02.003","volume":"42","author":"A Montoya","year":"2019","unstructured":"Montoya A, Varela-Ramirez A, Dickerson E, et al. The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer. Biomed J. 2019;42:155\u201365.","journal-title":"Biomed J"},{"key":"4870_CR293","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1007\/s00018-004-4102-3","volume":"61","author":"VA Pavlov","year":"2004","unstructured":"Pavlov VA, Tracey KJ. Neural regulators of innate immune responses and inflammation. Cell Mol Life Sci. 2004;61:2322\u201331.","journal-title":"Cell Mol Life Sci"},{"key":"4870_CR294","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/ni1229","volume":"6","author":"WJ de Jonge","year":"2005","unstructured":"de Jonge WJ, van der Zanden EP, The FO, et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the jak2-stat3 signaling pathway. Nat Immunol. 2005;6:844\u201351.","journal-title":"Nat Immunol"},{"key":"4870_CR295","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1067\/mva.2002.129643","volume":"36","author":"TR Bernik","year":"2002","unstructured":"Bernik TR, Friedman SG, Ochani M, et al. Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J Vasc Surg. 2002;36:1231\u20136.","journal-title":"J Vasc Surg"},{"key":"4870_CR296","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.immuni.2025.06.003","volume":"58","author":"G Li","year":"2025","unstructured":"Li G, Zhang C, Li Y, et al. Optogenetic vagal nerve stimulation attenuates heart failure by limiting the generation of monocyte-derived inflammatory ccrl2+ macrophages. Immunity. 2025;58:1847-1861.e9.","journal-title":"Immunity"},{"key":"4870_CR297","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1016\/j.lfs.2007.01.002","volume":"80","author":"M Gallowitsch-Puerta","year":"2007","unstructured":"Gallowitsch-Puerta M, Pavlov VA. Neuro-immune interactions via the cholinergic anti-inflammatory pathway. Life Sci. 2007;80:2325\u20139.","journal-title":"Life Sci"},{"key":"4870_CR298","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.813472","volume":"16","author":"H Chen","year":"2022","unstructured":"Chen H, Feng Z, Min L, et al. Vagus nerve stimulation reduces neuroinflammation through microglia polarization regulation to improve functional recovery after spinal cord injury. Front Neurosci. 2022;16:813472.","journal-title":"Front Neurosci"},{"key":"4870_CR299","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2023285119","volume":"119","author":"AS Caravaca","year":"2022","unstructured":"Caravaca AS, Gallina AL, Tarnawski L, et al. Vagus nerve stimulation promotes resolution of inflammation by a mechanism that involves alox15 and requires the \u03b17nachr subunit. Proc Natl Acad Sci U A. 2022;119:e2023285119.","journal-title":"Proc Natl Acad Sci U A"},{"key":"4870_CR300","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1405205","volume":"7","author":"KM Kokolus","year":"2017","unstructured":"Kokolus KM, Zhang Y, Sivik JM, et al. Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice. Oncoimmunology. 2017;7:e1405205.","journal-title":"Oncoimmunology"},{"key":"4870_CR301","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1158\/1078-0432.CCR-20-2381","volume":"27","author":"S Gandhi","year":"2021","unstructured":"Gandhi S, Pandey MR, Attwood K, et al. Phase i clinical trial of combination propranolol and pembrolizumab in locally advanced and metastatic melanoma: safety, tolerability, and preliminary evidence of antitumor activity. Clin Cancer Res. 2021;27:87\u201395.","journal-title":"Clin Cancer Res"},{"key":"4870_CR302","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1681\/ASN.0000000813","volume":"36","author":"E Goggins","year":"2025","unstructured":"Goggins E, Inoue H, Okusa MD. Neuroimmune control of inflammation in acute kidney injury and multiorgan dysfunction. J Am Soc Nephrol. 2025;36:2473\u201384.","journal-title":"J Am Soc Nephrol"},{"key":"4870_CR303","volume":"15","author":"B Li","year":"2023","unstructured":"Li B, Jin J, Guo D, et al. Immune checkpoint inhibitors combined with targeted therapy: the recent advances and future potentials. Cancers. 2023;15:309.","journal-title":"Cancers"},{"key":"4870_CR304","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s00262-020-02574-z","volume":"69","author":"E Nizam","year":"2020","unstructured":"Nizam E, K\u00f6ksoy S, Erin N. NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences. Cancer Immunol Immunother. 2020;69:1639\u201350.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"4870_CR305","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/mdb2.70001","volume":"1","author":"S Song","year":"2025","unstructured":"Song S, Liu Z, Wang Y, et al. Human organoids and their application in tumor models, disease modeling, and tissue engineering. Med Bull. 2025;1(1):17\u201336.","journal-title":"Med Bull"},{"key":"4870_CR306","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jaci.2024.02.006","volume":"153","author":"S Gupta","year":"2024","unstructured":"Gupta S, Viotti A, Eichwald T, et al. Navigating the blurred path of mixed neuroimmune signaling. J Allergy Clin Immunol. 2024;153:924\u201338.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"4870_CR307","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49824-7","volume":"15","author":"Y Hou","year":"2024","unstructured":"Hou Y, Lin B, Xu T, et al. The neurotransmitter calcitonin gene-related peptide shapes an immunosuppressive microenvironment in medullary thyroid cancer. Nat Commun. 2024;15(1):5555.","journal-title":"Nat Commun"},{"key":"4870_CR308","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41586-022-05374-w","volume":"611","author":"M Balood","year":"2022","unstructured":"Balood M, Ahmadi M, Eichwald T, et al. Nociceptor neurons affect cancer immunosurveillance. Nature. 2022;611:405\u201312.","journal-title":"Nature"},{"key":"4870_CR309","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1152\/jappl.1995.78.4.1234","volume":"78","author":"CM Lilly","year":"1995","unstructured":"Lilly CM, Hall AE, Rodger IW, et al. Substance p-induced histamine release in tracheally perfused guinea pig lungs. J Appl Physiol. 1995;78:1234\u201341.","journal-title":"J Appl Physiol"},{"key":"4870_CR310","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1365-2222.1995.tb01024.x","volume":"25","author":"LG Heaney","year":"1995","unstructured":"Heaney LG, Cross LJ, Stanford CF, et al. Substance p induces histamine release from human pulmonary mast cells. Clin Exp Allergy. 1995;25:179\u201386.","journal-title":"Clin Exp Allergy"},{"key":"4870_CR311","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41416-019-0640-1","volume":"122","author":"M Sola-Penna","year":"2019","unstructured":"Sola-Penna M, Paix\u00e3o LP, Branco JR, et al. Serotonin activates glycolysis and mitochondria biogenesis in human breast cancer cells through activation of the jak1\/stat3\/erk1\/2 and adenylate cyclase\/pka, respectively. Br J Cancer. 2019;122:194\u2013208.","journal-title":"Br J Cancer"},{"key":"4870_CR312","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075426","volume":"8","author":"M Bader","year":"2013","unstructured":"Bader M, Nau F, Yu B, et al. Serotonin 5-ht2a receptor activation blocks tnf-\u03b1 mediated inflammation in vivo. PLoS ONE. 2013;8:e75426.","journal-title":"PLoS ONE"},{"key":"4870_CR313","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1365-2249.2007.03492.x","volume":"150","author":"G M\u00e9nard","year":"2007","unstructured":"M\u00e9nard G, Turmel V, Bissonnette EY. Serotonin modulates the cytokine network in the lung: involvement of prostaglandin e2. Clin Exp Immunol. 2007;150:340\u20138.","journal-title":"Clin Exp Immunol"},{"key":"4870_CR314","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1158\/0008-5472.CAN-23-3628","volume":"84","author":"T Passang","year":"2024","unstructured":"Passang T, Wang S, Zhang H, et al. VPAC2 receptor signaling promotes growth and immunosuppression in pancreatic cancer. Cancer Res. 2024;84:2954\u201367.","journal-title":"Cancer Res"},{"key":"4870_CR315","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.canlet.2019.12.015","volume":"472","author":"C Lin","year":"2020","unstructured":"Lin C, Ren Z, Yang X, et al. Nerve growth factor (ngf)-trka axis in head and neck squamous cell carcinoma triggers emt and confers resistance to the egfr inhibitor erlotinib. Cancer Lett. 2020;472:81\u201396.","journal-title":"Cancer Lett"},{"key":"4870_CR316","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10549-024-07263-4","volume":"206","author":"OW Scott","year":"2024","unstructured":"Scott OW, TinTin S, Cavadino A, et al. Beta-blocker use and breast cancer outcomes: a meta-analysis. Breast Cancer Res Treat. 2024;206:443\u201363.","journal-title":"Breast Cancer Res Treat"},{"key":"4870_CR317","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41551-023-01107-0","volume":"8","author":"AR Kline-Schoder","year":"2024","unstructured":"Kline-Schoder AR, Chintamen S, Willner MJ, et al. Characterization of the responses of brain macrophages to focused ultrasound-mediated blood-brain barrier opening. Nat Biomed Eng. 2024;8:650\u201363.","journal-title":"Nat Biomed Eng"},{"key":"4870_CR318","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114539","volume":"190","author":"J Wang","year":"2022","unstructured":"Wang J, Li Z, Pan M, et al. Ultrasound-mediated blood-brain barrier opening: an effective drug delivery system for theranostics of brain diseases. Adv Drug Deliv Rev. 2022;190:114539.","journal-title":"Adv Drug Deliv Rev"},{"key":"4870_CR319","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115323","volume":"209","author":"P Zhao","year":"2024","unstructured":"Zhao P, Wu T, Tian Y, et al. Recent advances of focused ultrasound induced blood-brain barrier opening for clinical applications of neurodegenerative diseases. Adv Drug Deliv Rev. 2024;209:115323.","journal-title":"Adv Drug Deliv Rev"},{"key":"4870_CR320","doi-asserted-by":"publisher","first-page":"6521","DOI":"10.1038\/s41598-021-85180-y","volume":"11","author":"ZK Englander","year":"2021","unstructured":"Englander ZK, Wei H-J, Pouliopoulos AN, et al. Focused ultrasound mediated blood-brain barrier opening is safe and feasible in a murine pontine glioma model. Sci Rep. 2021;11:6521.","journal-title":"Sci Rep"},{"key":"4870_CR321","doi-asserted-by":"publisher","first-page":"1577331","DOI":"10.3389\/fphar.2025.1577331","volume":"16","author":"MA Mujtaba","year":"2025","unstructured":"Mujtaba MA, Rashid MA, Godbole MD, et al. Escitalopram oxalate-loaded chitosan nanoparticle in situ gel formulation intended for direct nose-to-brain delivery: in vitro, ex vivo, and in vivo pharmacokinetic evaluation. Front Pharmacol. 2025;16:1577331.","journal-title":"Front Pharmacol"},{"key":"4870_CR322","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jconrel.2023.12.054","volume":"366","author":"Q Huang","year":"2024","unstructured":"Huang Q, Chen Y, Zhang W, et al. Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases. J Control Release. 2024;366:519\u201334.","journal-title":"J Control Release"},{"key":"4870_CR323","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s11095-024-03790-3","volume":"41","author":"H Zeng","year":"2024","unstructured":"Zeng H, Lu H, Yang J, et al. An update on recent drug delivery systems targeting brain diseases via the transnasal pathway. Pharm Res. 2024;41:2121\u201341.","journal-title":"Pharm Res"},{"key":"4870_CR324","doi-asserted-by":"crossref","unstructured":"Xu D, Song X-J, Chen X, et al. Advances and future perspectives of intranasal drug delivery: a scientometric review. J Control Release Off J Control Release Soc. 2024;367:366\u201384.","DOI":"10.1016\/j.jconrel.2024.01.053"},{"key":"4870_CR325","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115239","volume":"207","author":"J Liu","year":"2024","unstructured":"Liu J, Cabral H, Mi P. Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release. Adv Drug Deliv Rev. 2024;207:115239.","journal-title":"Adv Drug Deliv Rev"},{"key":"4870_CR326","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.4103\/NRR.NRR-D-24-00048","volume":"20","author":"M Zhang","year":"2025","unstructured":"Zhang M, Xiang C, Niu R, et al. Liposomes as versatile agents for the management of traumatic and nontraumatic central nervous system disorders: drug stability, targeting efficiency, and safety. Neural Regen Res. 2025;20:1883\u201399.","journal-title":"Neural Regen Res"},{"key":"4870_CR327","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1080\/17425247.2023.2245332","volume":"20","author":"Y Wei","year":"2023","unstructured":"Wei Y, Xia X, Li H, et al. Influence factors on and potential strategies to amplify receptor-mediated nanodrug delivery across the blood-brain barrier. Expert Opin Drug Deliv. 2023;20:1713\u201330.","journal-title":"Expert Opin Drug Deliv"},{"key":"4870_CR328","volume":"8","author":"W Zhang","year":"2021","unstructured":"Zhang W, Mehta A, Tong Z, et al. Development of polymeric nanoparticles for blood-brain barrier transfer-strategies and challenges. Adv Sci Weinh Baden-Wurtt Ger. 2021;8:2003937.","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"4870_CR329","volume":"15","author":"C Ekhator","year":"2023","unstructured":"Ekhator C, Qureshi MQ, Zuberi AW, et al. Advances and opportunities in nanoparticle drug delivery for central nervous system disorders: a review of current advances. Cureus. 2023;15:e44302.","journal-title":"Cureus"},{"key":"4870_CR330","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41578-024-00695-w","volume":"9","author":"J Gao","year":"2024","unstructured":"Gao J, Xia Z, Gunasekar S, et al. Precision drug delivery to the central nervous system using engineered nanoparticles. Nat Rev Mater. 2024;9:567\u201388.","journal-title":"Nat Rev Mater"},{"key":"4870_CR331","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbi.2023.11.004","volume":"115","author":"I Boyton","year":"2024","unstructured":"Boyton I, Valenzuela SM, Collins-Praino LE, et al. Neuronanomedicine for alzheimer\u2019s and parkinson\u2019s disease: current progress and a guide to improve clinical translation. Brain Behav Immun. 2024;115:631\u201351.","journal-title":"Brain Behav Immun"},{"key":"4870_CR332","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115274","volume":"208","author":"E Perolina","year":"2024","unstructured":"Perolina E, Meissner S, Raos B, et al. Translating ultrasound-mediated drug delivery technologies for cns applications. Adv Drug Deliv Rev. 2024;208:115274.","journal-title":"Adv Drug Deliv Rev"},{"key":"4870_CR333","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125753","volume":"680","author":"N Jan","year":"2025","unstructured":"Jan N, Shah H, Shi G. Biomimetic approaches against accelerated blood clearance (abc) phenomenon of nanoparticulate drug delivery systems. Int J Pharm. 2025;680:125753.","journal-title":"Int J Pharm"},{"key":"4870_CR334","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1038\/s41592-024-02316-4","volume":"21","author":"Y Long","year":"2024","unstructured":"Long Y, Ang KS, Sethi R, et al. Deciphering spatial domains from spatial multi-omics with spatialglue. Nat Methods. 2024;21:1658\u201367.","journal-title":"Nat Methods"},{"key":"4870_CR335","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s40478-023-01639-1","volume":"11","author":"V Amani","year":"2023","unstructured":"Amani V, Riemondy KA, Fu R, et al. Integration of single-nuclei rna-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of nf1-associated plexiform neurofibromas. Acta Neuropathol Commun. 2023;11:158.","journal-title":"Acta Neuropathol Commun"},{"key":"4870_CR336","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s40364-024-00654-1","volume":"12","author":"X Xiong","year":"2024","unstructured":"Xiong X, Wang X, Liu C-C, et al. Deciphering breast cancer dynamics: insights from single-cell and spatial profiling in the multi-omics era. Biomark Res. 2024;12:107.","journal-title":"Biomark Res"},{"key":"4870_CR337","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092190","author":"X Tan","year":"2022","unstructured":"Tan X, Bednarsch J, Rosin M, et al. PD-1+ t-cells correlate with nerve fiber density as a prognostic biomarker in patients with resected perihilar cholangiocarcinoma. Cancers. 2022;14:2190.","journal-title":"Cancers"},{"key":"4870_CR338","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fchem.2014.00105","volume":"2","author":"J Conniot","year":"2014","unstructured":"Conniot J, Silva JM, Fernandes JG, et al. Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking. Front Chem. 2014;2:105.","journal-title":"Front Chem"},{"key":"4870_CR339","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.70045","volume":"4","author":"X Dai","year":"2025","unstructured":"Dai X, Wang M, Liu Y. A hiplot-based web service for cold atmospheric plasma high-throughput data integration and analysis on breast cancer. iMeta. 2025;4:e70045.","journal-title":"iMeta"},{"key":"4870_CR340","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108322","volume":"26","author":"C Huang","year":"2023","unstructured":"Huang C, Deng M, Leng D, et al. MIRS: an ai scoring system for predicting the prognosis and therapy of breast cancer. Iscience. 2023;26:108322.","journal-title":"Iscience"},{"key":"4870_CR341","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41746-024-01043-6","volume":"7","author":"Y Li","year":"2024","unstructured":"Li Y, Wu X, Fang D, et al. Informing immunotherapy with multi-omics driven machine learning. Npj Digit Med. 2024;7:67.","journal-title":"Npj Digit Med"},{"key":"4870_CR342","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2024.100859","volume":"42","author":"S Brem","year":"2024","unstructured":"Brem S. Vagus nerve stimulation: novel concept for the treatment of glioblastoma and solid cancers by cytokine (interleukin-6) reduction, attenuating the sasp, enhancing tumor immunity. Brain Behav Immun-Health. 2024;42:100859.","journal-title":"Brain Behav Immun-Health"},{"key":"4870_CR343","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202207029","volume":"19","author":"C Yang","year":"2023","unstructured":"Yang C, He Y, Chen F, et al. Leveraging \u03b2-adrenergic receptor signaling blockade for improved cancer immunotherapy through biomimetic nanovaccine. Small. 2023;19:e2207029.","journal-title":"Small"},{"key":"4870_CR344","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100633","volume":"20","author":"S Zeng","year":"2023","unstructured":"Zeng S, Tang Q, Xiao M, et al. Cell membrane-coated nanomaterials for cancer therapy. Mater Today Bio. 2023;20:100633.","journal-title":"Mater Today Bio"},{"key":"4870_CR345","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202103208","volume":"33","author":"X Yang","year":"2021","unstructured":"Yang X, McGlynn E, Das R, et al. Nanotechnology enables novel modalities for neuromodulation. Adv Mater. 2021;33:e2103208.","journal-title":"Adv Mater"},{"key":"4870_CR346","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.immuni.2021.04.007","volume":"54","author":"M Schiller","year":"2021","unstructured":"Schiller M, Azulay-Debby H, Boshnak N, et al. Optogenetic activation of local colonic sympathetic innervations attenuates colitis by limiting immune cell extravasation. Immunity. 2021;54:1022-1036.e8.","journal-title":"Immunity"},{"key":"4870_CR347","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","volume":"24","author":"R Polak","year":"2024","unstructured":"Polak R, Zhang ET, Kuo CJ. Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment. Nat Rev Cancer. 2024;24:523\u201339.","journal-title":"Nat Rev Cancer"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04870-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04870-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04870-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:20:45Z","timestamp":1781742045000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04870-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":347,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4870"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04870-4","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors declare no conflict of interest and are published uniformly.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"360"}}